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Abstract 
 
5-Aminolevulinate synthase (ALAS) catalyzes the pyridoxal 5’-phosphate (PLP)-
dependent condensation between glycine and succinyl-CoA to generate coenzyme A (CoA), 
CO2, and 5-aminolevulinate (ALA). The chemical mechanism of this reaction, which represents 
the first and regulated step of heme biosynthesis in mammals, involves the formation of a short-
lived glycine quinonoid intermediate and an unstable 2-amino-3-ketoadipate intermediate. Using 
liquid chromatography coupled with tandem mass spectrometry to analyze the products from the 
reaction of murine erythroid ALAS (mALAS2) with O-methylglycine and succinyl-CoA, we 
directly identified the chemical nature of the inherently unstable 2-amino-3-ketoadipate 
intermediate, which predicates the glycine quinonoid species as its precursor. With stopped-flow 
absorption spectroscopy, we detected and confirmed the formation of the quinonoid intermediate 
upon reacting glycine with ALAS. Significantly, in the absence of the succinyl-CoA substrate, 
the external aldimine predominates over the glycine quinonoid intermediate. When instead of 
glycine, L-serine was reacted with ALAS, a lag phase was observed in the progress curve for the 
L-serine external aldimine formation, indicating a hysteretic behavior in ALAS. Hysteresis was 
not detected in the T148A-catalyzed L-serine external aldimine formation. These results with 
T148A, a mALAS2 variant, which, in contrast to the wild-type enzyme, is active with L-serine, 
suggest that the active site T148 modulates the strict amino acid substrate specificity of ALAS. 
The rate of ALA release is also controlled by a hysteretic kinetic mechanism (observed as a lag 
xi 
 
in the ALA external aldimine formation progress curve), consistent with conformational changes 
governing the dissociation of ALA from ALAS. 
In Rhodobacter capsulatus ALAS, apart from coordinating the positioning of succinyl-
CoA, N85 has an important role in regulating the opening of an active site channel. Here, we 
have mutated the analogous asparagine of murine erythroid ALAS to a histidine (N150H) and 
assessed its effects on catalysis through steady-state and pre-steady-state kinetic studies. 
Quinonoid intermediate formation occurred with a significantly reduced rate for the N150H-
catalyzed condensation of glycine with succinyl-CoA during a single turnover. When the same 
forward reaction was examined under multiple turnovers, the progress curve of the N150H 
reaction displayed a prolonged decay of the quinonoid intermediate into the steady-state, distinct 
from the steep decay in the wild-type ALAS reaction. This prolonged decay results from an 
accelerated transformation of the product, ALA, into the quinonoid intermediate during the 
reverse N150H-catalyzed reaction. In fact, while wild-type ALAS catalyzes the conversion of 
ALA into the quinonoid intermediate at a rate 6.3-fold lower than the formation of the same 
quinonoid intermediate from glycine and succinyl-CoA, the rate for the N150H-catalyzed reverse 
reaction is 1.7-fold higher than that of the forward reaction. We conclude that N150 is important 
in establishing a catalytic balance between the forward and reverse reactions, by favoring ALA 
synthesis over its non-productive transformation into the quinonoid intermediate. Mutations at 
this position could perturb the delicate heme biosynthetic equilibrium. 
Circular dichroism (CD) and fluorescence spectroscopies were used to examine the 
effects of pH (1.0-3.0 and 7.5-10.5) and temperature (20 and 37 °C) on the structural integrity of 
ALAS. The secondary structure, as deduced from far-UV CD, is mostly resilient to pH and 
temperature changes. Partial unfolding was observed at pH 2.0, but further decreasing pH 
xii 
 
resulted in acid-induced refolding of the secondary structure to nearly native levels. The tertiary 
structure rigidity, monitored by near-UV CD, is lost under acidic and specific alkaline conditions 
(pH 10.5 and pH 9.5/37 °C), where ALAS populates a molten globule state. As the enzyme 
becomes less structured with increased alkalinity, the chiral environment of the internal aldimine 
is also modified, with a shift from a 420 nm to 330 nm dichroic band. Under acidic conditions, 
the PLP cofactor dissociates from ALAS. Reaction with 8-anilino-1-naphtalenesulfonic acid 
corroborates increased exposure of hydrophobic clusters in the alkaline and acidic molten 
globules, although the reaction is more pronounced with the latter. Furthermore, quenching the 
intrinsic fluorescence of ALAS with acrylamide at pH 1.0 and 9.5 yielded subtly different 
dynamic quenching constants. The alkaline molten globule state of ALAS is catalytically active 
(pH 9.5/37 °C), although the kcat value is significantly decreased. Finally, the binding of 5-
aminolevulinate restricts conformational fluctuations in the alkaline molten globule.  Overall, our 
findings prove how the structural plasticity of ALAS contributes to reaching a functional 
enzyme. 
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Chapter One 
 
Introduction 
 
The importance of heme for the existence of all living organisms is paramount. This 
tetrapyrrolic compound, which consists of iron bound to protoporphyrin IX, serves as a 
prosthetic group for a number of proteins involved in the transport and storage of divalent gasses, 
redox reactions, and electron transport (1, 2). Even though in all organisms the first committed 
step of heme biosynthesis represents the formation of 5-aminolevulinate (ALA), the precursors 
used for its synthesis differ (2). In plants, archaea, and most bacteria, ALA is synthesized in a 
two-enzymatic step reaction from glutamyl-tRNA (2). This pathway, known as the C5-pathway, 
entails the initial reduction of glutamyl-tRNA into glutamate-1-semialdehyde by the enzyme 
glutamyl-tRNA reductase (2). Then, glutamate-1-semialdehyde-2,1-aminomutase converts 
glutamate-1-semialdehyde into ALA (2). In contrast, heme biosynthesis in non-plant eukaryotes 
and some bacteria proceeds via the C4-pathway (also known as the Shemin pathway), in which 
ALA is formed from the enzymatic condensation of glycine and succinyl-CoA by the pyridoxal 
5’-phosphate (PLP)-dependent enzyme 5-aminolevulinate synthase (ALAS) (2-4). The central 
focus of this dissertation will be ALAS. In this chapter, introduction to the seminal discoveries 
related to the mechanism, structure, and regulation of the enzyme is provided that will serve to 
guide the reader into subsequent chapters where original experimental work is presented.  
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Historical perspective1 
 Discovery of ALAS and its substrates and products 
During the mid-1940s, significant effort was invested toward identification of the initial 
precursors of heme, with most work being conducted in the laboratories of David Shemin and 
Albert Neuberger. In fact, it was David Shemin who initially demonstrated in 1945 that all four 
nitrogen atoms of the tetrapyrrolic ring of heme are derived from the amino group of glycine (5). 
He came to this conclusion after ingesting 66 g of 32% 15[N] glycine in addition to his usual diet, 
and observing that the isotopic nitrogen atoms are being incorporated in heme molecules isolated 
from his own blood (5). Once glycine was discovered as the initial precursor of heme, it was 
further demonstrated that only the alpha carbons of glycine are incorporated into the heme 
molecule (6), indicating that 24 out of the 32 carbons of heme must be derived from a molecule 
other than glycine. This led to the suggestion of a four-carbon asymmetric TCA cycle 
intermediate as a potential precursor of heme, resulting in the proposal and subsequent 
corroboration of succinyl-CoA as being that precursor (7). 
With the identification of glycine and succinyl-CoA as the initial substrates of heme 
biosynthesis, it was postulated that condensation between the two substrates at the α-carbon of 
glycine would result in the formation of α-amino-β-ketoadipic acid (8, 9). Decarboxylation of the 
α-amino-β-ketoadipic acid at the original α-carbon of glycine will then result in the formation of 
5-aminolevulinic acid (ALA), and it was proposed that ALA could potentially serve as the 
source for all nitrogen and carbon atoms of the heme molecule (8, 9). Synthesized chemically in 
                                                            
1Note to reader.  Portions of this section (i.e., Historical Perspective) were published as a book chapter in The 
Handbook of Porphyrin Science (4) [Fratz, E. J., Stojanovski, B.M., and Ferreira G.C (2013) Toward Heme: 5-
Aminolevulinate Synthase and Initiation of Porphyrin Biosyntehsis. The Handbook of Porphyrin Science (Ferreira, 
G.C., Kadish, K.M., Smith, K.M., and Guilard, R. Eds) World Scientific Publishing Co., Singapore. pp 1-78]. B. M. 
Stojanovski contributed equally in writing this book chapter and the section used in this dissertation was written by 
him. 
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the laboratories of Shemin and Neuberger, it was demonstrated that ALA is capable of inducing 
heme synthesis (8, 9). Briefly, it was shown that heme synthesized in avian erythrocytes from 
ALA labeled with either 15N or 14C contained significantly higher concentration of the isotopic 
label in comparison to heme that was synthesized from glycine labeled with either 15N or 14C (9). 
It was also demonstrated that the addition of unlabeled ALA significantly reduced the isotopic 
activity of heme that was synthesized in the presence of either 14C glycine or 14C succinate (9). 
The results strongly suggested that ALA is indeed an intermediate in the heme biosynthetic 
pathway that is formed upon the condensation of glycine and succinyl-CoA.  
The identification of ALA as an intermediate in heme biosynthesis was followed by 
reports of its enzymatic synthesis (10, 11). In 1958, the group of Neuberger reported the 
enzymatic biosynthesis of ALA in freeze-dried particles obtained from avian erythrocytes (10), 
and in the same year the group of Shemin reported the enzymatic biosynthesis of ALA in 
particle-free extracts obtained from Rhodopseudomonas spheroides and Rhodospirillum rubrum 
(11). In all cases, it was clearly demonstrated that the substrates utilized by the enzyme in the 
synthesis of ALA were glycine and succinyl-CoA. With the identification of ALAS, along with 
its substrates and products, the identity of the enzyme that initiates heme biosynthesis was finally 
resolved. 
 
 Discovery of the internal aldimine and its tautomeric species 
In 1958 the research groups of Shemin and Neuberger independently demonstrated that 
PLP is required as an essential cofactor for the reaction catalyzed by ALAS (10, 11). It was 
observed that the formation of ALA in bacterial and avian extracts was dependent on the 
presence of PLP; omission of the cofactor from the reaction system resulted in decreased 
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formation of ALA, suggesting that PLP is required for catalysis (10, 11). In all PLP-dependent 
enzymes, the PLP cofactor is bound covalently through a Schiff base to the ε-amino group of an 
active site lysine, forming what is commonly referred to as an internal aldimine (12). In the case 
of ALAS, however, certain disparities were noted in opinions regarding the interaction between 
the enzyme and cofactor, with some investigators proposing an active site cysteine to be 
involved in the interaction with the cofactor (13-15). 
In contrast with the research groups that postulated an interaction with a sulfhydryl 
group, Nandi (16) proposed and validated that the PLP cofactor was bound to the ε-amino group 
of an active site lysine through a Schiff base linkage. In order to examine the possibility that a 
lysine was involved in the covalent interaction with the cofactor, Nandi (16) reduced R. 
spheroides ALAS with sodium borohydride in the presence of PLP, and examined acid-
hydrolyzed fractions for the presence of ε-N-pyridoxyllysine. Observation of a single fluorescent 
spot on a paper chromatogram whose mobility was identical to the one of chemically synthesized 
ε-N-pyridoxyllysine that served as a reference, was suggestive of the presence of ε-N-
pyridoxyllysine in the acid hydrolytes sample. Therefore, Nandi (16) concluded that the PLP-
cofactor was bound covalently to the ε-amino group of lysine, resulting in the formation of an 
internal aldimine (16). In agreement with these findings, Ferreira et al. (17) identified the exact 
lysine residue involved in the formation of the ε-N-pyridoxyllysine in murine erythroid ALAS 
(henceforth abbreviated as mALAS2). After reducing recombinant mALAS2 with tritiated 
sodium borohydride, the enzyme was digested with trypsin; the generated peptides were 
separated using high pressure liquid chromatography, and most of the tritium label was found in 
a single fraction. The sequence of the tritium-labeled peptide was determined, establishing that 
K313 (murine ALAS2 numbering) was bound to the PLP cofactor through a Schiff base linkage 
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(17). Importantly, when K313 was mutated to a glycine, alanine, or histidine, the cofactor no 
longer formed a Schiff base linkage with the active site lysine, but rather, it was bound non-
covalently to the enzyme, as a free aldehyde (18). The subsequent elucidation of the crystal 
structure of Rhodobacter capsulatus ALAS corroborated that the PLP cofactor is indeed bound 
to the ε-amino group of an active site lysine (19).  
Detailed characterizations of the spectroscopic properties of ALAS have contributed to 
the elucidation of the different tautomeric structures assumed by the internal aldimine (Fig. 1.1). 
The absorbance spectra of mALAS2 in the absence of substrates revealed the presence of two 
absorption bands: one with an absorbance maximum at 330 nm and another with an absorbance 
maximum at 410 nm (20). As with other PLP-dependent enzymes, the absorption peak at 410 nm 
was assigned to the ketoenamine form of the internal aldimine (Figure 1.1) (20). The absorption 
peak at 330 nm was assigned to the substituted aldamine form of the internal aldimine (Figure 
1.1), since a fluorescence emission maximum around 385 nm was observed upon excitation of 
the enzyme at 330 nm (20). In theory, the 330 nm-absorption species could have been assigned 
to an enolimine tautomer; however, if that were the case then excitation of ALAS at 330 nm 
would have resulted in a fluorescence emission maximum at ~515 and not at 385 nm (20). The 
spectral data strongly suggested that the 330 nm absorption band represented the substituted 
aldimine species (20). 
 
Figure 1.1. Tautomeric structures of the internal aldimine. (A) Ketoenamine, Absmax = ~420 nm, (B) 
Substituted aldamine, Absmax = ~330 nm, (C) Enolimine, Absmax = ~330 nm.  
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 Elucidation of the reaction mechanism 
 
With the identification that the activity of ALAS depends on PLP, Kikuchi et al. (11) 
proposed a putative mechanism for the reaction catalyzed by ALAS, based on the assumption 
that PLP is required in the activation of glycine. These investigators proposed that in order for 
glycine and succinyl-CoA to condense at the α-carbon of glycine, formation of a carbanion 
intermediate, resulting from the cleavage of one of the bonds to the α-carbon of glycine, would 
be required. Since it was recognized that the carbanion intermediate could be formed either from 
decarboxylation or deprotonation of the α-carbon, two different reaction mechanisms were 
considered (11). In the first mechanism, the carbanion intermediate was envisioned to result from 
decarboxylation of the glycyl carboxyl group. Then, condensation with succinyl-CoA would 
produce ALA upon the release of the coenzyme-A moiety. In the second mechanism, the 
carbanion intermediate, which would arise from removal of one of the hydrogen atoms bonded to 
the glycine α-carbon, would condense with succinyl-CoA to yield an α-amino-β-ketoadipate 
intermediate. The subsequent decarboxylation of the α-amino-β-ketoadipate intermediate would 
either be spontaneous (i.e. non-enzymatic) upon the release of the intermediate from the enzyme 
or occur on the surface of the enzyme, with ALAS acting as a decarboxylase.  Numerous studies 
followed (discussed briefly on the following pages) that allowed us to distinguish between these 
two putative mechanisms, and the refined chemical mechanism is outlined in Scheme 1.1 (see 
legend for summary). 
The individual steps of the chemical reaction mechanism of ALAS were mainly resolved 
with the initiation of a series of radiolabeling experiments. Akhtar and Jordan (21) were the first  
to clarify the differences between the two potential mechanisms, demonstrating that the 
formation of the initial carbanion intermediate involves the abstraction of one of the α-protons of 
glycine. Upon the incubation of enzyme preparations of R. sphaeroides ALAS with 2RS [3H2] 
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glycine and succinyl-CoA it was observed that only half of the tritium label was retained in ALA 
(21). 
 
 
 
Scheme 1.1: Proposed chemical mechanism for the reaction catalyzed by ALAS. In the resting state, 
PLP binds covalently to an active site lysine as an internal aldimine (I) [PLP-K313 internal aldimine in 
mALAS2]. The entry of glycine in the active site proceeds with the formation of an external aldimine (II). 
Removal of the pro-R proton of glycine results in formation of a first quinonoid intermediate (III), which 
facilitates the condensation with succinyl-CoA and subsequent release of the CoA moiety (IV). When the 
resulting 2-amino-3-ketoadipate intermediate (V) is decarboxylated (H207-assisted decarboxylation in the 
mALAS2 reaction), an enol intermediate is formed (VI) which is in rapid equilibrium with a second 
quinonoid intermediate (VII). The final reaction intermediate is the ALA external aldimine (VIII). 
  
 
 
8 
 
Retention of one-half of the original tritium label in ALA indicated a reaction involving 
deprotonation of the α-carbon, for if the reaction involved initial decarboxylation, then the entire 
tritium label would have been retained in ALA. Therefore, the researchers concluded that the 
carbanion intermediate is formed as a result of the abstraction of one of the α-protons of glycine 
(21). To test whether the abstraction of the proton was catalyzed in a stereospecific manner, 
Jordan and Akhtar (22) used serine transhydroxymethylase to generate pro-R and pro-S 
enantiomers of glycine. Incubation of these enantiomers with R. sphaeroides ALAS established 
that the pro-R proton is abstracted from glycine, and the formation of the carbanion intermediate 
is stereospecifically catalyzed (23).  
Once it was established that the reaction mechanism entails initial deprotonation of 
glycine, it became evident that condensation between the resulting carbanion and succinyl-CoA 
would involve formation of an α-amino-β-ketoadipate intermediate. Further, in order for ALA to 
be formed from the α-amino-β-ketoadipate intermediate, decarboxylation at the original α-carbon 
would have to occur, which in theory can either be spontaneous (i.e., non-enzymatic) or 
enzymatic.  Evidence in favor of enzymatic decarboxylation of this intermediate emerged from 
the finding that upon incubation of ALAS with tritiated pro-S enantiomer of glycine, the tritium 
label was found in the S-configuration at the C5 position of ALA (24). If decarboxylation were 
to be non-enzymatic then the C-5 position of ALA was going to be racemic. Demonstration of 
the reversibility of the ALAS-catalyzed reaction provided further evidence in support of 
enzymatic decarboxylation and established that the enzyme can act as decarboxylase (25).  
In agreement with a mechanism that entails initial deprotonation of glycine, Hunter and 
Ferreira (26) identified K313 of mALAS2 as the amino acid that acts as a base-catalyst during 
the abstraction of the pro-R proton from glycine. This is the same amino acid that forms a Schiff 
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base linkage with the PLP cofactor in the absence of substrates (17). It was demonstrated that 
while the reaction of wild type mALAS2 with [2-3H2]-glycine resulted in loss of one-half of the 
original tritium label within the first hour of the reaction, there was no detectable loss of tritium 
label in the reaction of the K313G variant with [2-3H2]-glycine, strongly supporting that K313 is 
the catalytic base that removes the pro-R proton of glycine (26).  
In many PLP-dependent enzymes, the PLP cofactor functions to stabilize negative charge 
development on the C-α of the amino acid substrate, by facilitating delocalization of the 
electrons through the  system of the pyridinium ring (12). The resulting carbanions are termed 
quinonoid intermediates, displaying absorbance maximum at ~510 nm (12). In fact, the 
spectroscopic detection of a quinonoid intermediate was particularly useful in elucidating the 
kinetic mechanism of ALAS (27-29). Characterization of the pH dependence of the mALAS2-
catalyzed formation of the quinonoid intermediate during pre-steady state kinetic analyses 
revealed an acid catalyzed process (29). Since radiolabeling studies had demonstrated that K313 
facilitates initial deprotonation of glycine by acting as a base catalyst (26), while the quinonoid 
intermediate transiently detectable during pre-steady state kinetic analyses was catalyzed in an 
acid-dependent manner, Hunter et al. (29) proposed that the spectroscopically detectable 
intermediate must be the second quinonoid intermediate which results from decarboxylation of 
the α-amino-β-ketoadipate intermediate, rather than the initial quinonoid intermediate formed 
upon deprotonation of glycine. Based on structural modeling of the α-amino-β-ketoadipate 
intermediate in the active site of ALAS, it was suggested that an active site histidine (H207 in 
mALAS2) can act as an acid catalyst by protonating the β-keto carbonyl oxygen the α-amino-β-
ketoadipate, which would facilitate decarboxylation and subsequent formation of the quinonoid 
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intermediate that is predicted to be in a rapid equilibrium with an enol (29).  The refined 
mechanism is summarized in Scheme 1.1. 
 
The Crystal structure of R. capsulatus ALAS 
The crystal structure of R. capsulatus ALAS reveals a homodimeric enzyme whose 
individual monomers consist of three separate domains (Fig. 1.2) (19). As with other fold type I 
PLP-dependent enzymes, the enzymatic active site is located at the dimeric interface, and is 
composed of amino acids from the individual monomers. In the active site of the holoenzyme, 
PLP is bound covalently to the ε-amino group of K248 (R. capsulatus ALAS numbering) 
through a Schiff base linkage (Fig. 1.3A) (19). The pyridinium ring of the resulting internal 
aldimine is positioned between H142 and V216, with each amino acid stacking the ring from an 
opposite side. Interactions with H217 and D214 are not only important for proper positioning of 
PLP, but also for enhancing the electron sink function of the cofactor during catalysis (30, 31). 
The phosphate group further stabilizes the positioning of PLP by forming six different hydrogen 
bonds with active site amino acids from each monomer (19). 
The binding of glycine in the active site results in the formation of an external aldimine 
with PLP (Fig. 1.3B) (19). Non-covalent interactions with S189, N54, and R374 (R. capsulatus 
ALAS) stabilize the positioning of glycine within the active site, and the salt bridge with R374 is 
particularly important in attaining a catalytically favorable orientation, as evident from the 
abolished activity that ensued when the analogous arginine was mutated to a leucine in mALAS2 
(32). Upon binding to ALAS, succinyl-CoA establishes interactions with all three domains of the 
individual monomer as well as interactions with the catalytic domain of the opposite monomer 
(Fig. 1.3C) (19). The adenosyl group binds in a hydrophobic pocket located on the surface of the 
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enzyme. Within this pocket, the ribose moiety of succinyl-CoA forms a hydrogen bond with 
K156, whereas the adenine group forms hydrogen bonds with S137, D138, and S139, ensuring 
specificity between the substrate and the enzyme. The adenine group is further stabilized by two 
hydrophobic amino acids, I146 and I158, positioned on either side of the ring. In contrast to the 
adenosyl moiety, the succinate group binds deep in the active site, where one of its carboxyl 
oxygen interacts with R21, T365, and N85, whereas the other oxygen forms a hydrogen bond 
with T83. The surface of the enzyme is connected to the active site pocket through an active site 
channel, which, in the succinyl-CoA-bound structure, is occupied by its pantetheine moiety. 
 
 
 
 
 
 
Figure 1.2. Crystal structure of homodimeric R. capsulatus ALAS. The N-terminal domain is shown 
in red, the catalytic domain in purple, and the C-terminal domain in cyan. The other subunit is in gray. 
PLP is shown as yellow sticks. PDB code: 2BWN. 
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Figure 1.3. The active site of R. capsulatus ALAS. (A) PLP bound covalently to the active site lysine as 
an internal aldimine, (B) glycine bound covalently to PLP as an external aldimine, (C) succinyl-CoA 
bound to the active site of ALAS. 
 
 
13 
 
Conformational changes and the reaction rate-limiting step 
Two distinctive conformations, open and closed, were observed in the crystal structure of 
R. capsulatus ALAS (Fig. 1.4) (19). During the transition between the open and closed 
conformations, segmental rearrangements result in the repositioning of a loop over the active site 
(residues 358-375 in R. capsulatus ALAS) that narrows the active site pocket of ALAS, and the 
mobility of this flexible loop is partly restricted by the binding of succinyl-CoA through 
interactions with the succinyl-pantetheine moiety. Further rearrangements during the 
conformational transitions entail the repositioning of a C-terminal helix and a short linker 
(residues 332-348 in R. capsulatus ALAS) toward the N-terminus. The fact that in all substrate-
bound structures ALAS assumes the closed conformation implicates that this conformation is the 
catalytically competent one. Interestingly, even though the structural rearrangements that induce 
conversion of ALAS to the closed conformation minimize the exposure of the active site to the 
solvent, the active site becomes fully protected from the solvent only upon the binding of 
succinyl-CoA. 
 
Figure 1.4. The crystal structure of R. capsulatus ALAS in the open (blue) and closed conformations 
(magenta). The active site loop which closes and opens over the active site is shown in the insert.  
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Detection of a pre-steady-state burst of ALA formation during quenched-flow kinetic 
analyses indicates that the reaction rate-limiting step occurs after the chemical formation of ALA 
(28). This observation, together with the evidence for structural repositioning of a flexible loop 
over the active site, has led to the proposal that the ALAS-catalyzed reaction is at least partly 
limited by a closed-to-open conformational transition that regulates the release of ALA from the 
active site (29). Even though the validity of this hypothesis needs to be examined, possibly by 
characterizing the rates of the conformational transitions, some evidence in its favor was 
provided by Lendrihas et al. (33) when multiple mutations were introduced in the flexible active 
site loop of mALAS2 and it was demonstrated that the kcat values of some variants were 
increased in comparison to the wild-type enzyme. The authors concluded that the mutations 
affected the ability of the enzyme variants to stabilize the closed conformation, resulting in faster 
reversion to the open conformation during product release (33). 
 
Differential regulation of the ALAS1 and ALAS2 isoforms 
In mammals, there are two different isoforms of the ALAS gene localized on different 
chromosomes: the non-specific isoform, ALAS1, is ubiquitously expressed in all tissues including 
erythroid and has been mapped to chromosome 3p21.1 (34); the erythroid-specific isoform, 
ALAS2, has been mapped to Xp11.21 (35) and is only expressed in erythroid cells, where it 
serves to meet the high requirements for heme during erythropoiesis. Furthermore, as discussed 
in the following pages, the two isoforms are regulated by different mechanisms. 
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 Transcriptional and translational regulation of ALAS1 
During its transcription, the ALAS1 gene is regulated in a heme-dependent manner 
through a classical feedback mechanism where inhibition of transcription occurs upon increased 
concentrations of intracellular heme (1). There are two different mechanisms that regulate the 
transcription of ALAS1. The first mechanism involves heme-dependent regulation of the 
peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) expression by the heme-
responsive, nuclear receptor Rev-erbα (36). PGC-1α is a coactivator that up-regulates the 
expression of ALAS1 through the recruitment of the transcription factors nuclear respiratory 
factor-1 (NRF-1) and FOXO1 to the respective NRF-1 and insulin regulatory elements (InsRE) 
located in the promoter of the ALAS1 gene (37). Increase in the intracellular levels of heme 
results in the binding of heme to Rev-erbα and recruitment of the repressor complex nuclear 
receptor co-repressor/histone deacetylase 3 (NCoR/HDAC3) to repress the transcription of PGC-
1α, which decreases the expression of ALAS1 (36). It is important to note that increased 
concentration of glucose also results in suppression of the ALAS1 gene in an insulin-dependent 
manner (37). This is accomplished by phosphorylation of FOXO1 through an insulin-mediated 
pathway and disruption of the interaction with PGC-1α (37). In the second mechanism, increased 
concentrations of intracellular heme result in the up-regulation of the transcription factor, early 
growth response 1 (Egr-1), which together with its major co-repressors NAB1/NAB2 binds to 
heme responsive elements located in the proximal promoter region of ALAS1 (38). This results in 
down-regulation of ALAS1. 
Even though the regulation of mammalian ALAS1 at the level of translation is poorly 
characterized, certain reports exist that translation is adversely affected by increased 
concentration of hemin (38, 39). Specifically, from in vitro studies it was concluded that 
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increased levels of hemin destabilized ALAS1 mRNA in hepatocytes (39), and decreased the rate 
of translation of ALAS1 in polysomes that were isolated from hepatocytes (40). 
 
 Post-translational regulation of ALAS1 
Like many other mitochondrial proteins, ALAS is synthesized in the cytosol as a 
precursor protein, whose N-terminal pre-sequence is necessary for its translocation into 
mitochondria (41). Once the enzyme is localized in the mitochondrial matrix, the pre-sequence is 
processed by a yet to be identified peptidase, resulting in the formation of the mature enzyme. 
Even though the pre-sequence is present in the ALAS1 and ALAS2 proteins, the amino acid 
sequence identity between their pre-sequences is only 24 % (41). However, conserved motifs, 
termed heme regulatory motifs (HRM), are present in the presequences, and are characterized by 
a peptide sequence whose core consists of an invariant Cys-Pro dipeptide (41). Besides two 
HRMs that are present in the presequence, another HRM was also identified in the mature 
protein (41). Lathrop and Timko (41) demonstrated the importance of these HRMs in regulating 
mitochondrial targeting by showing that hemin inhibits the translocation of precursor ALAS2 
into isolated mitochondria, and that the hemin-dependent inhibition can be mainly prevented 
upon replacement of the cysteines in either HRM with serines, strongly implicating that the 
inhibition is mediated by the binding of hemin to the HRMs. These findings were supported by 
the in vivo analyses of Munakata et al. (42) using quail fibroblasts, where the researchers 
demonstrated that the translocation of ALAS1 into mitochondria is inhibited by hemin, and that 
this process can be reversed upon mutations of the invariant HRM cysteines with serines. 
However, the authors observed hemin-dependent inhibition only of ALAS1, and not ALAS2, 
suggesting differences in the physiological regulation of the two isoenzymes (42).  
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Besides inhibiting the translocation of ALAS1, hemin was also shown to affect the 
stability of ALAS1 in mitochondria through proteolytic degradation. This degradation of ALAS1 
is mediated in a heme-dependent manner by the Lon peptidase 1, although it is not understood 
how the enzyme in the presence of heme is marked for proteolytc degradation (43).  
 
 Transcriptional regulation of ALAS2 
The regulation of the ALAS2 gene appears to be mediated by transcription factors that are 
essential for erythropoiesis. Kramer et al. (44) conducted functional analyses of the murine 
ALAS2 gene to identify the promoter region that is essential for optimal transcriptional 
activation, revealing an important role of the initial 714-bp of the proximal promoter. In this 
region, numerous putative regulatory elements were identified for the binding of erythroid 
transcriptional factors including: GATA-1, the erythroid Kruppel-like factor (EKLF)/Sp1, NF-
E2, and hypoxia inducible factor-1 (HIF-1) (44). Two proximal GATA-1 binding sites were 
found to be necessary for optimal transcriptional activation (44).  
Hofer et al. (45) reported that hypoxic conditions (1 % O2) up-regulate the expression of 
the mALAS2 gene. Under hypoxic conditions, HIF-1 is known to up-regulate the expression of 
numerous genes essential for erythropoiesis including erythropoietin, transferrin, and the 
transferrin receptor (45). However, mutations in the putative HIF-1 binding site in the proximal 
promoter region of mALAS2 revealed that the hypoxic up-regulation is independent of this region 
(45). Further studies by Zhang et al. (46) with human ALAS2 corroborated up-regulation of the 
gene under hypoxic conditions. The authors also identified three putative responsive elements for 
binding of HIF-1 located downstream of the human ALAS2 gene. Reporter gene analyses and 
mutagenesis studies had shown that these responsive elements are necessary for optimal 
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transcriptional activation, and chromatin immunoprecipitation had shown HIF-1 to associate 
with the downstream responsive elements (46). 
Interestingly, introns 1 and 8 of the human ALAS2 gene were found to act as enhancers of 
transcriptional activation (47). Within intron 8, two CACCC boxes and one GATA motif were 
shown to be necessary for the enhancement of activity. These regions associate with Sp1 and 
GATA-1, although ectopic expression of the two proteins in erythroid cells did not increase basal 
expression of ALAS2, suggesting the involvement of a yet to be identified transcription factor 
necessary for activation (47). 
 
 Translational regulation of ALAS2 
Through binding to iron responsive elements (IRE), iron regulatory proteins (IRPs) are 
known to regulate the level of mRNA translation of several proteins essential for iron and heme 
metabolism (48). IREs were identified in the mRNAs sequences of the following proteins: 
ferritin (49), transferrin receptor 1 (TfR1) (50), ferroportin (51), divalent metal transporter 1 
(52), and ALAS2 (53). The binding of IRP to the IRE might inhibit or stimulate translation, 
depending on the localization of the IRE (48). If the IRE is present in the 5’ untranslated region 
of the mRNA (e.g., ALAS2 and ferritin), then binding of IRP will inhibit translation (48), 
supposedly by preventing the binding of the 43s translation initiation complex (54). In contrast, 
association of IRP with IREs localized in the 3’ untranslated regions of mRNAs (e.g., TfR1) tend 
to stimulate translation by minimizing RNAse mediated degradation (48). Two different IRPs 
have been identified that bind to IREs in iron depleted cells. IRP1 is a bifunctional protein that 
associates with IREs under iron depleted conditions, whereas upon iron repletion, its iron-sulfur 
cluster is assembled and the protein functions as a cytosolic aconitase (55). In contrast, during 
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iron repletion, IRP2 is degraded by the proteasome through a mechanism that involves iron-
mediated oxidation and ubiquitination (56). This translational mechanism mediated by IRPs 
closely regulates heme and iron metabolism, allowing for the translation of ALAS2 and ferritin 
to occur during iron repletion, which would result in the sequestration of iron in heme or ferritin, 
and thus, preventing its toxic buildup (1). During iron deficiency, in contrast, the biosynthesis 
and accumulation of toxic porphyric intermediates is prevented by inhibition of ALAS2 
translation through the binding of IRPs to its mRNAs (1). 
 
Disorders associated with mutations in the ALAS2 gene 
X-linked sideroblastic anemia (XLSA) is a hematopoietic disorder characterized by 
microcytic, hypochromic anemia, and in specific cases, systemic iron overload (57). XLSA 
results from loss-of-function mutations in the ALAS2 gene, and rarely, mutations in the proximal 
promoter region (57). Since the ALAS2 gene is located on the X-chromosome, the pattern of 
inheritance is X-linked, predominantly affecting males, although females are also affected as a 
result of lyonization (57). Prophylaxis of the disease primarily includes management of the 
anemia and prevention of iron overload. About ¾ of patients respond to treatment with 
pyridoxine, which like PLP is another B6 vitamer (57). 
Astner et al. (19) used the crystal structure of R. capsulatus ALAS to map specific XLSA 
mutations on the enzyme. Mutations were assigned in four groups depending on the proximity to 
the active site: 1) ALAS2 mutations present in pyridoxine-responsive patients, which tend to 
cluster in the PLP-binding site and affect the binding or positioning of the cofactor, 2) Mutations 
that disrupt the integrity of the active site by altering amino acids involved in catalysis, substrate 
binding or positioning, and are typically present in patients who are not responsive to pyridoxine 
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treatment, 3) Mutations in amino acids located in the protein interior, distant from the active site, 
that may impact stability or structural integrity which may weaken binding of substrates and/or 
PLP cofactor, and thus hinder catalysis, and 4) Mutations on the protein surface that impede 
protein-protein interactions and/or affect protein stability. 
X-linked dominant protoporphyria (XLDPP), results from gain-of-function mutations in 
the ALAS2 gene (58). The first case of XLDPP was reported in 2008, and in contrast to other 
porphyrias, where mutations either decrease the enzymatic activity or stability, XLDPP 
mutations result in proteins whose catalytic activity is increased over the wild-type enzyme (58). 
Clinically, XLDPP is characterized by an excessive accumulation of protoporphyrin IX and zinc-
protoporphyrin in erythrocytes, resulting in photosensitivity and liver complications (58). The 
increased ALAS2 activity leads to protoporphyin production in quantities greater than the 
available ferrous iron for heme synthesis. All of the identified XLDPP mutations fall into the last 
protein-coding exon of the ALAS2 gene and result in frameshifts that lead to substitution or 
deletion of the 20 C-terminal amino acids of ALAS2 (58). 
 
Contents of the dissertation 
The central focus of this dissertation is ALAS. Chapter II deals with the characterization 
of unstable reaction intermediates and reaction selectivity, with a particular emphasis on the 
hysteretic kinetic behavior detectable upon reaction of ALAS with non-physiological substrates 
and products. Chapter III focuses on the importance of N150 in establishing a catalytic balance 
between the forward and reverse reactions. In chapter IV, evidence is provided that ALAS can 
function as a catalytically active molten globular enzyme under specific pH and temperature 
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dependent conditions. Finally, chapter V provides a summary of the results and their 
significance. 
 
 
References 
 
1. Furuyama, K., Kaneko, K., and Vargas, P. D. (2007) Heme as a magnificent molecule 
with multiple missions: heme determines its own fate and governs cellular homeostasis. 
Tohoku. J. Exp. Med. 213, 1-16 
2. Layer, G., Reichelt, J., Jahn, D., and Heinz, D. W. (2010) Structure and function of 
enzymes in heme biosynthesis. Protein Sci. 19, 1137-1161 
3. Hunter, G. A., and Ferreira, G. C. (2011) Molecular enzymology of 5-aminolevulinate 
synthase, the gatekeeper of heme biosynthesis. Biochim. Biophys. Acta 1814, 1467-1473 
4. Fratz, E. J., Stojanovski, B. M., and Ferreira, G. C. (2013) Toward Heme: 5-
Aminolevulinate Synthase and Initiation of Porphyrin Synthesis. in The Handbook of 
Porphyrin Science (Ferreira, G. C., Kadish, K. M., Smith, K. M., and Guilard, R. eds.), 
World Scientific Publishing Co., Singapore. pp 1-78 
5. Shemin, D., and Rittenberg, D. (1946) The biological utilization of glycine for the 
synthesis of the protoporphyrin of hemoglobin. J. Biol. Chem. 166, 621-625 
6. Altman, K. I., Casarett, G. W., Masters, R. E., Noonan, T. R., and Salomon, K. (1948) 
Hemoglobin synthesis from glycine labeled with radioactive carbon in its α-carbon atom. 
J. Biol. Chem. 176, 319-325 
7. Shemin, D., and Wittenberg, J. (1951) The mechanism of porphyrin formation; the role of 
the tricarboxylic acid cycle. J. Biol. Chem. 192, 315-334 
22 
 
8. Neuberger, A., and Scott, J. J. (1953) Aminolaevulinic acid and porphyrin biosynthesis. 
Nature 172, 1093-1094 
9. Shemin, D., and Russell, C. S. (1953) δ-Aminolevulinic acid, its role in the biosynthesis 
of porphyrins and purines. J. Amer. Chem. Soc. 75, 4873-4875 
10. Gibson, K. D., Laver, W. G., and Neuberger, A. (1958) Initial stages in the biosynthesis 
of porphyrins. 2. The formation of d-aminolaevulic acid from glycine and succinyl-
coenzyme A by particles from chicken erythrocytes. Biochem. J. 70, 71-81 
11. Kikuchi, G., Kumar, A., Talmage, P., and Shemin, D. (1958) The enzymatic synthesis of 
d-aminolevulinic acid. J. Biol. Chem. 233, 1214-1219 
12. Eliot, A. C., and Kirsch, J. F. (2004) PYRIDOXAL PHOSPHATE ENZYMES: 
Mechanistic, Structural, and Evolutionary Considerations. Annu. Rev. Biochem. 73, 383-
415 
13. Scholnick, P. L., Hammaker, L. E., and Marver, H. S. (1972) Souble -aminolevulinic acid 
synthetase of rat liver. I. Some properties of the partially purified enzyme. J. Biol. Chem. 
247, 4126-4131 
14. Scholnick, P. L., Hammaker, L. E., and Marver, H. S. (1972) Soluble -aminolevulinic 
acid synthetase of rat liver. II. Studies related to the mechanism of enzyme action and 
hemin inhibition. J. Biol. Chem. 247, 4132-4137 
15. Fanica-Gaignier, M., and Clement-Metral, J. (1973) 5-Aminolevulinic-acid synthetase of 
Rhodopseudomonas spheroides Y. Purification and some properties. Eur. J. Biochem. 40, 
13-18 
16. Nandi, D. L. (1978) d-Aminolevulinic acid synthase of Rhodobacter spheroides. Binding 
of pyridoxal phosphate to the enzyme. Arch. Biochem. Biophys. 188, 266-271 
23 
 
17. Ferreira, G. C., Neame, P. J., and Dailey, H. A. (1993) Heme biosynthesis in mammalian 
systems: evidence of a Schiff base linkage between the pyridoxal 5'-phosphate cofactor 
and a lysine residue in 5-aminolevulinate synthase. Protein Sci. 2, 1959-1965 
18. Ferreira, G. C., Vajapey, U., Hafez, O., Hunter, G. A., and Barber, M. J. (1995) 
Aminolevulinate synthase: lysine 313 is not essential for binding the pyridoxal phosphate 
cofactor but is essential for catalysis. Protein. Sci. 4, 1001-1006 
19. Astner, I., Schulze, J. O., van den Heuvel, J., Jahn, D., Schubert, W. D., and Heinz, D. W. 
(2005) Crystal structure of 5-aminolevulinate synthase, the first enzyme of heme 
biosynthesis, and its link to XLSA in humans. EMBO J. 24, 3166-3177 
20. Zhang, J., Cheltsov, A. V., and Ferreira, G. C. (2005) Conversion of 5-aminolevulinate 
synthase into a more active enzyme by linking the two subunits: Spectroscopic and 
kinetic properties. Protein Sci. 14, 1190-1200 
21. Akhtar, M., and Jordan, P. M. (1968) The mechanism of action of d-aminolaevulinate 
synthetase and the synthesis of stereospecifically tritiated glycine. Chem. Comm., 1691-
1692 
22. Jordan, P. M., and Akhtar, M. (1970) The mechanism of action of serine 
transhydroxymethylase. Biochem. J. 116, 277-286 
23. Zaman, Z., Jordan, P. M., and Akhtar, M. (1973) Mechanism and stereochemistry of the 
5-aminolaevulinate synthetase reaction. Biochem. J. 135, 257-263 
24. Abboud, M. M., Jordan, P. M., and Akhtar, M. (1974) Biosynthesis of 5-aminolevulinic 
acid: involvement of a retention-inversion mechanism. J. Chem. Soc. Chem. Comm., 643-
644 
24 
 
25. Nandi, D. L. (1978) Studies on d-aminolevulinic acid synthase of Rhodopseudomonas 
spheroides. Reversibility of the reaction, kinetic, spectral, and other studies related to the 
mechanism of action. J. Biol. Chem. 253, 8872-8877 
26. Hunter, G. A., and Ferreira, G. C. (1999) Lysine-313 of 5-aminolevulinate synthase acts 
as a general base during formation of the quinonoid reaction intermediates. Biochemistry 
38, 3711-3718 
27. Hunter, G. A., and Ferreira, G. C. (1999) Pre-steady-state reaction of 5-aminolevulinate 
synthase. Evidence for a rate-determining product release. J. Biol. Chem. 274, 12222-
12228 
28. Zhang, J., and Ferreira, G. C. (2002) Transient state kinetic investigation of 5-
aminolevulinate synthase reaction mechanism. J. Biol. Chem. 277, 44660-44669 
29. Hunter, G. A., Zhang, J., and Ferreira, G. C. (2007) Transient kinetic studies support 
refinements to the chemical and kinetic mechanisms of aminolevulinate synthase. J. Biol. 
Chem. 282, 23025-23035 
30. Turbeville, T. D., Zhang, J., Hunter, G. A., and Ferreira, G. C. (2007) Histidine 282 in 5-
aminolevulinate synthase affects substrate binding and catalysis. Biochemistry 46, 5972-
5981 
31. Gong, J., Hunter, G. A., and Ferreira, G. C. (1998) Aspartate-279 in aminolevulinate 
synthase affects enzyme catalysis through enhancing the function of the pyridoxal 5'-
phosphate cofactor. Biochemistry 37, 3509-3517 
32. Tan, D., Harrison, T., Hunter, G. A., and Ferreira, G. C. (1998) Role of arginine 439 in 
substrate binding of 5-aminolevulinate synthase. Biochemistry 37, 1478-1484 
25 
 
33. Lendrihas, T., Hunter, G. A., and Ferreira, G. C. (2010) Targeting the active site gate to 
yield hyperactive variants of 5-aminolevulinate synthase. J. Biol. Chem. 285, 13704-
13711 
34. Cotter, P. D., Drabkin, H. A., Varkony, T., Smith, D. I., and Bishop, D. F. (1995) 
Assignment of the human housekeeping delta-aminolevulinate synthase gene (ALAS1) to 
chromosome band 3p21.1 by PCR analysis of somatic cell hybrids. Cytogenet. Cell 
Genet. 69, 207-208 
35. Cotter, P. D., Willard, H. F., Gorski, J. L., and Bishop, D. F. (1992) Assignment of 
human erythroid delta-aminolevulinate synthase (ALAS2) to a distal subregion of band 
Xp11.21 by PCR analysis of somatic cell hybrids containing X; autosome translocations. 
Genomics 13, 211-212 
36. Wu, N., Yin, L., Hanniman, E. A., Joshi, S., and Lazar, M. A. (2009) Negative feedback 
maintenance of heme homeostasis by its receptor, Rev-erba. Genes Dev. 23, 2201-2209 
37. Handschin, C., Lin, J., Rhee, J., Peyer, A. K., Chin, S., Wu, P. H., Meyer, U. A., and 
Spiegelman, B. M. (2005) Nutritional regulation of hepatic heme biosynthesis and 
porphyria through PGC-1a. Cell 122, 505-515 
38. Gotoh, S., Nakamura, T., Kataoka, T., and Taketani, S. (2011) Egr-1 regulates the 
transcriptional repression of mouse d-aminolevulinic acid synthase 1 by heme. Gene 472, 
28-36 
39. Drew, P. D., and Ades, I. Z. (1989) Regulation of the stability of chicken embryo liver 
delta-aminolevulinate synthase mRNA by hemin. Biochem. Biophys. Res. Commun. 162, 
102-107 
26 
 
40. Yamamoto, M., Hayashi, N., and Kikuchi, G. (1983) Translational inhibition by heme of 
the synthesis of hepatic delta-aminolevulinate synthase in a cell-free system. Biochem. 
Biophys. Res. Commun. 115, 225-231 
41. Lathrop, J. T., and Timko, M. P. (1993) Regulation by heme of mitochondrial protein 
transport through a conserved amino acid motif. Science 259, 522-525 
42. Munakata, H., Sun, J. Y., Yoshida, K., Nakatani, T., Honda, E., Hayakawa, S., 
Furuyama, K., and Hayashi, N. (2004) Role of the heme regulatory motif in the heme-
mediated inhibition of mitochondrial import of 5-aminolevulinate synthase. J. Biochem. 
136, 233-238 
43. Tian, Q., Li, T., Hou, W., Zheng, J., Schrum, L. W., and Bonkovsky, H. L. (2011) Lon 
peptidase 1 (LONP1)-dependent breakdown of mitochondrial 5-aminolevulinic acid 
synthase protein by heme in human liver cells. J. Biol. Chem. 286, 26424-26430 
44. Kramer, M. F., Gunaratne, P., and Ferreira, G. C. (2000) Transcriptional regulation of the 
murine erythroid-specific 5-aminolevulinate synthase gene. Gene 247, 153-166 
45. Hofer, T., Wenger, R. H., Kramer, M. F., Ferreira, G. C., and Gassmann, M. (2003) 
Hypoxic up-regulation of erythroid 5-aminolevulinate synthase. Blood 101, 348-350 
46. Zhang, F. L., Shen, G. M., Liu, X. L., Wang, F., Zhao, H. L., Yu, J., and Zhang, J. W. 
(2011) Hypoxic induction of human erythroid-specific d-aminolevulinate synthase 
mediated by hypoxia-inducible factor 1. Biochemistry 50, 1194-1202 
47. Surinya, K. H., Cox, T. C., and May, B. K. (1998) Identification and characterization of a 
conserved erythroid-specific enhancer located in intron 8 of the human 5-aminolevulinate 
synthase 2 gene. J. Biol. Chem. 273, 16798-16809 
27 
 
48. Rouault, T. A. (2006) The role of iron regulatory proteins in mammalian iron 
homeostasis and disease. Nat. Chem. Biol. 2, 406-414 
49. Hentze, M. W., Caughman, S. W., Rouault, T. A., Barriocanal, J. G., Dancis, A., Harford, 
J. B., and Klausner, R. D. (1987) Identification of the iron-responsive element for the 
translational regulation of human ferritin mRNA. Science 238, 1570-1573 
50. Casey, J. L., Hentze, M. W., Koeller, D. M., Caughman, S. W., Rouault, T. A., Klausner, 
R. D., and Harford, J. B. (1988) Iron-responsive elements: regulatory RNA sequences 
that control mRNA levels and translation. Science 240, 924-928 
51. McKie, A. T., Marciani, P., Rolfs, A., Brennan, K., Wehr, K., Barrow, D., Miret, S., 
Bomford, A., Peters, T. J., Farzaneh, F., Hediger, M. A., Hentze, M. W., and Simpson, R. 
J. (2000) A novel duodenal iron-regulated transporter, IREG1, implicated in the 
basolateral transfer of iron to the circulation. Mol. Cell 5, 299-309 
52. Gunshin, H., Mackenzie, B., Berger, U. V., Gunshin, Y., Romero, M. F., Boron, W. F., 
Nussberger, S., Gollan, J. L., and Hediger, M. A. (1997) Cloning and characterization of 
a mammalian proton-coupled metal-ion transporter. Nature 388, 482-488 
53. Dandekar, T., Stripecke, R., Gray, N. K., Goossen, B., Constable, A., Johansson, H. E., 
and Hentze, M. W. (1991) Identification of a novel iron-responsive element in murine 
and human erythroid delta-aminolevulinic acid synthase mRNA. EMBO J. 10, 1903-1909 
54. Gray, N. K., and Hentze, M. W. (1994) Iron regulatory protein prevents binding of the 
43S translation pre-initiation complex to ferritin and eALAS mRNAs. EMBO J. 13, 
3882-3891 
55. Paraskeva, E., and Hentze, M. W. (1996) Iron-sulphur clusters as genetic regulatory 
switches: the bifunctional iron regulatory protein-1. FEBS Lett. 389, 40-43 
28 
 
56. Iwai, K., Drake, S. K., Wehr, N. B., Weissman, A. M., LaVaute, T., Minato, N., 
Klausner, R. D., Levine, R. L., and Rouault, T. A. (1998) Iron-dependent oxidation, 
ubiquitination, and degradation of iron regulatory protein 2: implications for degradation 
of oxidized proteins. Proc. Natl. Acad. Sci. U. S. A. 95, 4924-4928 
57. Bottomley, S. S. (2004) Sideroblastic Anemias. in Wintrobe's Clinical Hematology 
(Greer, J., Foerster, J., Lukens, J. N., Rodgers, G. M., Paraskevas, R., and Glader, R. B. 
eds.), Williams and Wilkins, Philadelphia. pp 1011-1033 
58. Whatley, S. D., Ducamp, S., Gouya, L., Grandchamp, B., Beaumont, C., Badminton, M. 
N., Elder, G. H., Holme, S. A., Anstey, A. V., Parker, M., Corrigall, A. V., Meissner, P. 
N., Hift, R. J., Marsden, J. T., Ma, Y., Mieli-Vergani, G., Deybach, J. C., and Puy, H. 
(2008) C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-
linked dominant protoporphyria without anemia or iron overload. Am. J. Hum. Genet. 83, 
408-414 
 
 
 
 
 
 
 
 
 
 
 
29 
 
 
 
 
Chapter Two 
Unstable reaction intermediates and hysteresis during the catalytic cycle of  
5-aminolevulinate synthase2 
 
Abstract 
5-Aminolevulinate (ALA), an essential metabolite in all heme-synthesizing organisms, 
results from the pyridoxal 5’-phosphate (PLP)-dependent enzymatic condensation of glycine 
with succinyl-CoA in non-plant eukaryotes and some bacteria. The predicted chemical 
mechanism of this ALA synthase (ALAS)-catalyzed reaction includes a transient glycine 
quinonoid intermediate and an unstable 2-amino-3-ketoadipate intermediate. Using liquid 
chromatography coupled with tandem mass spectrometry to analyze the products from the 
reaction of murine erythroid ALAS (mALAS2) with O-methylglycine and succinyl-CoA, we 
directly identified the chemical nature of the inherently unstable 2-amino-3-ketoadipate 
intermediate, which predicates the glycine quinonoid species as its precursor. With stopped-flow 
absorption spectroscopy, we detected and confirmed the formation of the quinonoid intermediate 
upon reacting glycine with ALAS. Significantly, in the absence of the succinyl-CoA substrate, 
the external aldimine predominates over the glycine quinonoid intermediate. When instead of 
glycine, L-serine was reacted with ALAS, a lag phase was observed in the progress curve for the 
L-serine external aldimine formation, indicating a hysteretic behavior in ALAS. Hysteresis was 
not detected in the T148A-catalyzed L-serine external aldimine formation. These results with 
                                                            
2 Note to reader. Portion of this research was originally published in the Journal of Biological Chemistry (1). 
[Stojanovski et al. Unstable reaction intermediates and hysteresis during the catalytic cycle of 5-aminolevulinate 
synthase: Implications from using pseudo and alternate substrates and a promiscuous enzyme variant. J. Biol.Chem. 
2014, 289:22915-22925. © The American Society for Biochemistry and Molecular Biology] 
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T148A, a mALAS2 variant, which, in contrast to wild-type mALAS2, is active with L-serine, 
suggest that the active site T148 modulates the strict specificity of ALAS toward the amino acid 
substrate. The rate of ALA release is also controlled by a hysteretic kinetic mechanism (observed 
as a lag in the ALA external aldimine formation progress curve), consistent with conformational 
changes governing the dissociation of ALA from ALAS.   
 
Introduction 
5-Aminolevulinate synthase (ALAS) catalyzes the condensation between glycine and 
succinyl-CoA to generate CoA, CO2, and ALA (1-3). This reaction is the first, and main 
regulatory, step of heme biosynthesis in mammals. There are two isoforms of the mammalian 
ALAS gene: a non-specific and ubiquitously expressed isoform (ALAS1) and an erythroid-
specific isoform (ALAS2) (2, 3). Loss-of-function mutations in the human ALAS2 gene result in 
X-linked sideroblastic anemia (4), whereas gain-of-function mutations lead to X-linked dominant 
protoporphyria (5).  
ALAS belongs to the α-oxoamine synthase family of PLP-dependent enzymes, whose 
members catalyze a condensation between a small amino acid and an acyl-CoA thioester (2, 6-
10). The enzyme is a homodimer with its active site located at the dimeric interface (11). At least 
two different conformations define ALAS: a catalytically incompetent, open conformation and a 
catalytically competent, closed conformation (12, 13). Interconversion between these two 
conformations appears closely linked to catalysis (13, 14). Namely, the rate limiting step of the 
overall ALAS-catalyzed reaction is proposed to represent a conformational rearrangement from 
the closed to the open conformation, which is concomitant with the release of ALA from the 
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active site (13, 14). However, how the protein conformational changes are reflected in the last 
steps of the ALAS kinetic mechanism has not yet been examined.  
      The proposed sequence of reaction events catalyzed by ALAS is outlined in Scheme 2.1. 
The initial catalytic event involves displacement of the Schiff base linkage between a conserved, 
active site lysine [(i.e., K313 in murine ALAS2 (15)] and the PLP cofactor (I) by the incoming 
glycine substrate to form an external aldimine (II). Removal of one of the two glycine α-carbon 
hydrogen atoms results in a quinonoid intermediate (III). A Claisen condensation of this 
intermediate (III) with the succinyl-CoA substrate leads to CoA release and generation of the -
ketoacid aldimine complex (V), which then decarboxylates to yield a second quinonoid 
intermediate, the quinonoid of the ALA product (VII).  Findings from early radiolabeling studies, 
using Rhodobacter sphaeroides ALAS and stereospecifically tritiated pro-R and pro-S 
enantiomers of glycine, allowed investigators to reach two major conclusions: 1) ALAS 
catalyzes the  abstraction of the pro-R proton of glycine, giving a stabilized carbanion, the 
quinonoid intermediate (III), and  2) the postulated ALAS-bound 2-amino-3-ketoadipate 
intermediate is enzymatically decarboxylated (16, 17). Subsequently, two conserved, active site 
amino acids, a lysine, which is linked through a Schiff base to PLP, and a histidine, located 
directly above the plane of the PLP ring, (i.e., K313 and H207 in murine ALAS2), were 
identified as the catalytic amino acids involved in the proton abstraction and decarboxylation 
steps, respectively (14, 18) (Scheme 2.1). 
   Despite the efforts made in the last decade towards identifying the specific reaction 
intermediates (i.e., Scheme 2.1, III and V) and defining a general reaction mechanism for the -
oxoamine synthase family (2, 6-8, 19, 20), direct evidence of the chemical and spectroscopic 
nature of these intermediates has been unattainable. Kerbarh et al. (19) used the methyl ester of  
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Scheme 2.1. Proposed chemical mechanism for the reaction catalyzed by ALAS. In the resting state, 
PLP binds covalently to an active site lysine as an internal aldimine (I) [PLP-K313 internal aldimine in 
mALAS2]. The entry of glycine in the active site proceeds with the formation of an external aldimine (II). 
Removal of the pro-R proton of glycine results in formation of a first quinonoid intermediate (III), which 
facilitates the condensation with succinyl-CoA and subsequent release of the CoA moiety (IV). When the 
resulting 2-amino-3-ketoadipate intermediate (V) is decarboxylated (H207-assisted decarboxylation in the 
mALAS2 reaction), an enol intermediate is formed (VI) which is in rapid equilibrium with a second 
quinonoid intermediate (VII). The final reaction intermediate is the ALA external aldimine (VIII). 
 
L-alanine as a pseudo-substrate to establish that the proposed quinonoid intermediate in the 8-
amino-7-oxononanoate synthase (AONS)-catalyzed reaction resulted from proton abstraction, 
and not decarboxylation, of the AONS-alanine external aldimine. Similarly, formation of the 
initial quinonoid intermediate could be spectroscopically observed upon binding of either glycine 
or glycine and succinyl-CoA to R. sphaeroides ALAS (21). The monitoring of this quinonoid 
intermediate was clearly facilitated in the R. capsulatus ALAS-catalyzed reaction by substituting 
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glycine with O-methylglycine (22), as the resulting methyl ester of the β-ketoacid-aldimine could 
not undergo enzymatic decarboxylation, and thus accumulated. However, even with the 
significant acceleration of the rate of quinonoid intermediate formation upon succinyl-CoA 
binding to ALAS (13, 23), neither the spectroscopic detection of the first quinonoid intermediate 
(Scheme 2.1, III) nor the determination of the chemical nature of the predicted 2-amino-3-
ketoadipate intermediate (V) in the mALAS2-catalyzed reaction have yet been achieved, mainly 
due to the transient and unstable nature of the III and V intermediates (3, 14).    
  In contrast to the strict specificity for glycine as the only amino acid substrate, ALAS can 
utilize other acyl-CoA derivatives in addition to succinyl-CoA (24, 25). An important 
determinant in the specificity of ALAS toward the amino acid substrate is the positioning of a 
perfectly conserved active site threonine (22, 25). In fact, mutation of this threonine in ALAS 
from R. sphaeroides (25) or R. capsulatus (22) altered the amino acid substrate specificity of the 
enzyme. However, the kinetic, mechanistic, and conformational dynamic bases for this alteration 
remain unknown.  
  Here we report the direct identification of the 2-amino-3-ketoadipate intermediate, 
(Scheme 2.1, V) using glycine and O-methylglycine as substrate and pseudo-substrate, 
respectively, and a combination of stopped-flow kinetics and liquid chromatography coupled 
with tandem mass spectrometry (LC-MS/MS). This finding, together with the spectroscopic 
detection of the first quinonoid intermediate (Scheme 2.1, III) and consequent calculation of the 
rate constant associated with its formation, supports the occurrence of these two intermediates in 
the pathway of the ALAS-catalyzed reaction and confirms that the quinonoid intermediate (III) 
stems from deprotonation rather than decarboxylation of the ALAS-glycine external aldmine 
(Scheme 2.1, II). Further, and in contrast to the physiological glycine substrate, mALAS2 
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displayed hysteresis with L-serine, as indicated by the lag phase in the progress curve for the 
mALAS2-serine external aldimine production. We propose that this hysteretic behavior 
emanates from structural rearrangements induced by the different orientation of the bound L-
serine in the mALAS2 active site.  
 
Materials and methods 
Reagents   
The following reagents were obtained from Fisher Scientific: glycine, O-methylglycine 
(also known as glycine methyl ester, glycine O-methyl ester, methyl glycinate and methyl 2-
aminoacetate), potassium phosphate monobasic, potassium phosphate dibasic, HEPES, glycerol, 
HPLC grade methanol, HPLC grade acetonitrile, and sodium hydroxide. 5-Aminolevulinate 
hydrochloride was from Acros Organics, and L-serine, pyridoxal 5’-phosphate, deuterated 
glycine, and trimethylchlorosilane were from Sigma-Aldrich.  
 
Construction and isolation of the T148A variant  
The T148A variant was obtained by screening a library of mALAS2 variants for ALAS 
activity. Briefly, the codons for T148 and N150 of mALAS2 were simultaneously randomized 
using degenerate oligonucleotides. To screen the shuffling library for functional variants, we 
reversed the phenotype of Escherichia  coli hemA– (HU227) cells (26), which can survive only if 
they harbor functional ALAS or if ALA (or hemin) is added to the medium (27). DNA 
sequencing templates were prepared from colonies recovered on the selective medium and the 
T184A-encoding mutation was then identified by DNA sequencing.  
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Overproduction and purification of wild-type mALAS2 and T148A variant   
Protein overproduction and purification were performed as described previously (28). 
Following lysis of the cells, all purification steps were performed in one day and the 
concentrated, purified protein was stored under liquid nitrogen. Protein purity was assessed by 
SDS-PAGE. Protein concentrations were determined spectroscopically by monitoring the 
absorbance at 280 nm and using a molar extinction coefficient of 42860 M-1 cm-1 based on the 
mALAS2 amino acid sequence. 
 
Synthesis of deuterated O-methylglycine 
 Deuterated O-methylglycine was prepared from deuteroglycine and methanol at room 
temperature in the presence of trimethylsilane as previously described (29). 
      
mALAS2-catalyzed reaction with either glycine or O-methylglycine   
mALAS2 was reacted with glycine, O-methylglycine or deuterated O-methylglycine and 
succinyl-CoA in 300 µL of 20 mM HEPES, pH 7.5, containing 10% (v/v) glycerol, at 30 °C for 
120 minutes. The final concentrations in the reaction assays were 20 µM mALAS2, 100 μM 
succinyl-CoA, and 100 mM glycine, O-methylglycine or deuterated O-methylglycine. The 
control assay reactions were run under the above experimental conditions (i.e., same buffer, 
temperature and time) but solely with 1) mALAS2, 2) mALAS2 and glycine, 3) mALAS2 and 
O-methylglycine, 4) mALAS2 and deuterated O-methylglycine and 5) mALAS2 and succinyl-
CoA.  All of the above experimental and control reactions were run in duplicates, such that the 
reactions in one of the two sets were stopped by precipitation with 50% (vol) trichloroacetic acid.  
Briefly, trichloroacetic acid was added to each of these assay reactions (1:1, vol:vol), the 
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precipitated protein was removed by centrifugation, and the supernatant was stored in liquid 
nitrogen until the reaction intermediates present in the supernatant were analyzed by LC-MS/MS 
at the Sanford/Burnham Medical Research Institute, Lake Nona, Orlando, FL.   
      
Sample preparation for mass spectrometry  
  Twenty μl of each sample, previously thawed to room temperature, was combined with 
250 μl of HPLC grade acetonitrile in a 650 μl micro-centrifuge tube and vortexed for 5 minutes 
on a multi-tube vortex. The samples were then sonicated for 1 minute and centrifuged for 10 
minutes.  The supernatant was removed to a clean 96-well plate and evaporated to dryness under 
high purity N2 gas at 60 oC.  Prior to analysis by LC-MS/MS, the samples were reconstituted in 
200 μl of HPLC grade water, vortexed and centrifuged.   
 
Synthesis of the methyl ester of 2-amino-3-ketoadipate   
 5-Amino-6-methoxy-4,6-dioxo-hexanoic acid (i.e., the methyl ester of the putative 2-
amino-3-ketoadipate reaction intermediate)  was synthesized from benzyl alcohol as described in 
Appendix 1. 
 
Data acquisition   
Data acquisition, peak integration, and sample quantitation were performed using a Dell 
Precision 390 Desktop Computer with an Intel Core 2 Duo Processor, Microsoft Windows XP 
Professional and Analyst Software Version 1.4.2.   
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 Separation of the reaction intermediates by ultra-high pressure liquid chromatography 
(UPLC)  
  UPLC was performed using a Waters Acquity UPLC system (Waters Corp., Milford, 
MA).  Chromatographic separation of the reaction intermediates was achieved using an Acquity 
BEH C18 1.7 µ 2.1 x 50 mm UPLC column (Waters Corp.). A 0.1% formic acid in water and 
0.1% formic acid in acetonitrile solutions were prepared as mobile phases A and B, respectively. 
The flow rate was set at 0.4 mL/min and the injection volume was set at 1 µl. A linear gradient 
separation was used, with 10% of mobile phase B from 0 to 0.50 min, then 10% to 95% of 
mobile phase B over 0.50 min, holding for 0.80 min, after which returning to 100% A in 2.00 
min for initial conditioning.   
       
 Detection and characterization of the “trapped” intermediate by liquid 
chromatography coupled with tandem mass spectrometry (LC-MS/MS)   
  LC-MS/MS analysis (i.e., mass detection) was performed using an Applied Biosystems 
API4000 QTrap LC/MS/MS instrument (AB Sciex, Foster City, CA) equipped with a Turbo 
Ionspray (TIS) source. The mass spectrometer was operated in a positive ion mode monitoring 4 
transitions for ALAS reaction intermediates using optimized analyte-dependent parameters. The 
structure for the proposed “trapped” intermediate, 5-amino-6-methoxy-4,6-dioxo-hexanoic acid,  
is given in Fig. 2.1.   
      
 Stopped-flow absorption spectroscopy experiments  
  A Kintek stopped-flow apparatus (model SF-2001) was used to monitor transient changes 
in absorbance (at 420 nm or 510 nm) following rapid mixing of enzyme (mALAS2 or T148A 
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variant) and ligands (glycine, L-serine or ALA). All reactions were performed at 18 ºC in 50 mM 
phosphate (37 mM K2HPO4/13 mM KH2PO4), pH 7.5, containing 10% glycerol (v/v). For the 
reaction between wild-type mALAS2 and glycine, one of the syringes contained 60 µM wild-
type mALAS2 in the above 50 mM phosphate buffer, pH 7.5, whereas the other syringe 
contained 200 mM glycine in the same buffer. The final concentrations of the reactants upon 
mixing are reported in the figure legends. The same buffer (composition and concentration) and 
enzyme and amino acid substrate concentrations were used in the reaction between wild-type 
mALAS2 (or T148A variant) and L-serine. For the reaction between wild-type mALAS2 and 
ALA, one of the syringes contained 60 µM wild-type mALAS2 in the above 50 mM phosphate 
buffer, pH 7.5, while the other syringe contained 20 mM ALA in the same buffer. Prior to 
reacting mALAS2 with ALA, the 1 M ALA-HCl stock was neutralized with an equal volume of 
1 M NaOH. The final concentrations of wild-type mALAS2 and ALA in the observation 
chamber were 30 µM and 10 mM, respectively. Each time course for the different monitored 
reactions represents the average of three or more data sets. The time course data were fitted to 
either a single- or two-exponential equation (Eq 2.1) using the Kintek stopped-flow software 
ܣ ൌ ෍ܽ௜݁ି௞೔௧ ൅ 	ܿ
ଶ
௡ୀଵ
 
 
 
 where At is the absorbance at time t, a is the amplitude of each phase, k is the observed rate 
constant for each phase and c is the final absorbance. 
 
 
 
 (Eq. 2.1) 
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Results 
 Identification of the Claisen condensation intermediate by LC-MS/MS  
  The detection and characterization of the mALAS2-bound intermediate upon the reaction 
of mALAS2 with O-methylglycine (or deuterated O-methylglycine) and succinyl-CoA was 
carried out using LC-MS/MS. Samples were analyzed by full-scan Q1 positive and negative 
modes and multiple reaction monitoring (MRM) positive mode for the predicted ALAS 
intermediate (Fig. 2.1). A signal at 189-190 m/z was observed during the full scan mode in 
positive ionization, as expected for the methyl ester of the-ketoacid aldimine complex (i.e., the 
5-amino-6-methoxy-4,6-dioxohexanoic acid intermediate; Scheme 2.1, structure V; Figure 2.1A, 
Inset). To confirm this assignment, 5-amino-6-methoxy-4,6-dioxo-hexanoic acid was 
synthesized, the analyte-dependent parameters were optimized, and the reaction samples were re-
analyzed for the intermediate in the MRM mode. The peak corresponding to the trapped methyl 
ester of the -ketoacid intermediate was significantly present in the samples in which mALAS2 
was reacted with O-methyl glycine and succinyl-CoA (Figure 2.2). 
      
 Reaction between glycine and wild-type mALAS2  
  The reaction between wild-type mALAS2 and glycine was examined by monitoring the 
changes in absorbance, at either 420 nm or 510 nm, as a function of time, using stopped-flow 
spectroscopy (pH 7.5/18 °C). The absorbance increase at 420 nm was previously assigned to the 
formation of the glycine external aldimine, while that observed at 510 nm was ascribed to 
quinonoid intermediate formation (13). Due to the high Km for glycine [i.e., 12 mM (30)] and the 
difficulty in reaching mALAS2 concentrations greater than 600 M, the reaction was performed 
using multi-turnover conditions, with the substrate concentration in excess over that of the  
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Figure 2.1. Analysis of the trapped intermediate in the ALAS-catalyzed reaction of O-methylglycine 
with succinyl-CoA by LC-MS/MS. (A) UPLC profile of the reaction sample indicating that the retention 
time of the major species, which has a mass ion spectrum peak at 188.9 m/z, is 0.44 min. (B) MS/MS 
scan spectrum (abundance vs. m/z) of the 0.44 min-fraction derived from the reaction sample indicating 
that the predominant species, with a  peak at 188.9 m/z, is consistent with the molecular mass of 189.17 
for the predicted intermediate, 5-amino-6-methoxy-4,6-dioxohexanoic acid (inset in (A)). 
 
 
Fig. 2.2. MRM chromatogram for the intermediate in the mALAS2-catalyzed reaction of O-
methylglycine with succinyl-CoA 
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enzyme. The time course monitored at 420 nm for the reaction of 30 µm wild-type mALAS2 
with 100 mM glycine, at pH 7.5 and 18 ºC, was best described by a monophasic process with an 
observed rate constant of 0.080 ± 0.001 s-1 (Fig. 2.3A). Similarly, the time course data for the 
same reaction, when monitored at 510 nm, were best fit to a single-exponential equation, 
yielding virtually the same value for the observed rate constant (0.070 ± 0.001 s-1) (Fig. 2.3B). 
However, if one assumes that the extinction coefficients of the two quinonoid intermediates are 
similar, it becomes apparent that the extent of the formed glycine external aldimine and glycine 
quinonoid intermediates varied considerably. Comparison between the extent of glycine 
quinonoid intermediate produced in the absence of succinyl-CoA (Fig. 2.3B), as assessed by the 
maximum absorbance amplitude at 510 nm, and that in the presence of 100 M succinyl-CoA 
(data not shown), indicated that the amount of quinonoid intermediate formed in the absence of 
succinyl-CoA was approximately 4% of that produced in the presence of the succinyl-CoA 
substrate (i.e., ஺೙೚	ೄ಴೚ಲ
ఱభబ	೙೘
஺శೄ಴೚ಲఱభబ	೙೘
ൌ ଼	௫	ଵ଴షరଶ	௫	ଵ଴షమ ).  These results suggest that even though there is some 
interconversion between the two intermediates, the external aldimine is the predominant 
intermediate when the enzyme reacts with glycine in the absence of succinyl-CoA. 
 
  Reaction of L-serine with either wild-type mALAS2 or T148A 
   To address the question of the ALAS amino acid substrate specificity, the pre-steady state 
reaction between 30 µm wild-type mALAS2 and 100 mM L-serine, at pH 7.5, 18 ºC, was 
monitored by following the change in absorbance at 420 nm with time (Fig. 2.4A).  A distinctive 
lag phase was observed in the first 1.0 s of the kinetic trace for the external aldimine formation 
between L-serine and wild-type mALAS2 (Fig. 2.4A), which was not detected upon reaction 
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with glycine (Fig. 2.3A). Further, the reaction with L-serine follows a biphasic kinetic process 
(Fig. 2.4A).  
 
 
Figure 2.3. Reaction between wild-type mALAS2 (30 µM) and glycine (100 mM). (A) Progress curve 
for the formation of the glycine external aldimine monitored at 420 nm. The data (open purple circles) 
were fit to a single-exponential equation with an observed rate constant (k1) of 0.080 ± 0.001s-1 and 
amplitude (A1) of 4.00x10-3 ± 0.01x10-3. (B) Progress curve for the formation of the glycine quinonoid 
intermediate monitored at 510 nm. The data (open purple circles) were fit to a single-exponential equation 
with an observed rate constant (k1) of 0.070 ± 0.001s-1 and amplitude (A1) of 0.80x10-3 ± 0.01 x 10-3.  
 
       The pre-steady state reaction between 30 µM T148A mALAS2 and 100 mM L-serine (at 
pH 7.5 and 18 ºC) was also investigated by monitoring the progress of external aldimine 
production, as assessed by the increase in absorbance at 420 nm. The T148A variant, in contrast 
to wild-type mALAS2, is active when L-serine and succinyl-CoA are the substrates (data not 
shown). Interestingly, the lag phase observed in the progress curve for the wild-type mALAS2-
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catalyzed reaction with L-serine was not observed with the T148A variant under identical 
experimental conditions (Fig. 2.4B). This implies that the lag phase observed for the reaction 
between L-serine and wild-type mALAS2 most likely resulted from unfavorable steric clashes 
with active site amino acids; thus when the active site architecture is modified, as in the T148A 
variant, the binding of L-serine can take place, presumably by circumventing any unfavorable 
steric clashes.  
 
 
 
Figure 2.4. Reaction of either wild-type mALAS2 or T148A variant (30 µM) with L-serine (100 
mM). (A) Progress curve for the formation of the L-serine-mALAS2 external aldimine. The data points 
were fit to a two-exponential equation yielding the observed rate constants (k1 and k2) and amplitudes (A1 
and A2): k1=2.5 ± 0.2 s-1and A1=1.70x10-3 ± 0.01x10-3 for the fast phase, and k2=0.070 ± 0.001 s-1 and 
A2=3.80x10-3 ± 0.01x10-3 for the slow phase. The inset shows the first 10 s of the reaction. (B) Progress 
curve for the formation of the L-serine-T148A external aldimine. The data were fit to a single-exponential 
equation yielding the observed rate constant (k1) of 0.070 ± 0.001 s-1 and the amplitude (A1) of 6.80x10-3 
± 0.01x10-3.  
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 Reaction between ALA and wild-type mALAS2  
  The time dependence of the pre-steady state reaction between 30 µM wild-type mALAS2 
and 10 mM ALA, at pH 7.5 and 18 ºC, was examined by monitoring the change in absorbance at 
either 420 nm (Fig. 2.5A) or 510 nm (Fig. 2.5B). While a distinctive kinetic lag phase of 0.5 
seconds was observed in the progress curve for the formation of the ALA-ALAS external 
aldimine (Fig. 2.5A), no kinetic lag phase was detectable during the ALA-quinonoid 
intermediate formation (Fig. 2.5B).  
 
 
Figure 2.5. Reaction between wild-type mALAS2 (30 µM) and ALA (10 mM). (A) Progress curve for 
the formation of the ALA-mALAS2 external aldimine as monitored at 420 nm. The data points were fit to 
a two-exponential equation yielding the observed rate constants (k1 and k2) and amplitudes (A1 and A2): 
k1=4.7 ± 0.01 s-1 and A1=1.1x10-3 ± 0.07x10-3 for the fast phase, and k2=0.37 ± 0.003 s-1 and A2=5.2x10-3 
± 0.02x10-3 for the slow phase. The inset shows the first 2.5s of the reaction. (B) Progress curve for the 
formation of the ALA quinonoid intermediate as monitored at 510 nm. The observed rate constants (k1 
and k2) and amplitudes (A) were: k1=0.61 ± 0.01 s-1 and A1=4.50x10-3 ± 0.07x10-3 for the fast phase, and 
k2=0.08 ± 0.01s-1 and A2=1.50x10-3 ± 0.04x10-3 for the slow phase. 
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  Formation of the external aldimine and quinonoid intermediates were both best described 
as biphasic processes. The observed rates for the fast and slow phases associated with the time 
course at 420 nm were 4.70 s-1 and 0.37 s-1, respectively (Fig. 2.5A), whereas those pertinent to 
the time course at 510 nm were 0.61 s-1 and 0.08 s-1 (Fig. 2.5B).  
 
Discussion 
In this study, we provide direct evidence for the presence of the first quinonoid and -
ketoacid reaction intermediates in the catalytic pathway of ALAS and examine the amino acid 
substrate specificity and conformational transitions of ALAS by focusing on the hysteretic 
behavior of the enzyme. Soon after ALAS was purified (31, 32) and PLP proven to be a cofactor 
of the enzyme (31, 32), the major question about the ALAS mechanism centered on establishing 
whether the external aldimine between glycine and ALAS (i.e., II in Scheme 2.1) would be 
decarboxylated or deprotonated (16, 31, 33) to give a stabilized carbanion. Findings from 
radiolabeling studies, using R. sphaeroides and stereospecifically tritiated glycine, clearly 
pointed to the deprotonation route yielding a quinonoid intermediate (i.e., III in Scheme 2.1) (16, 
33). Further, the deprotonation was stereospecific, with the exclusive removal of the pro-R 
proton (16) and, ultimately, the pro-S proton of glycine retaining the S-configuration at C-5 of 
ALA (17). This latter observation indicated not only that the inferred-amino--ketoadipate 
intermediate (i.e., V in Scheme 2.1) was on the catalytic pathway, but also that its 
decarboxylation was catalyzed by the enzyme (17, 34). However, corroborating the presence of 
the condensation intermediate, resulting from the condensation of the glycine quinonoid 
intermediate with succinyl-CoA has proven to be challenging. This is partly because the 2-
amino-3-ketoadipate intermediate is very reactive, undergoes a fast decarboxylation, and is 
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difficult to trap (14). Moreover, even if one could successfully trap the 2-amino-3-ketoadipate 
intermediate on the enzyme, its spontaneous decarboxylation at physiological pH would still be 
rapid (35).  
   Due to the chemical liability of the 2-amino-3-ketoadipate intermediate, which precluded 
its direct detection, we resorted to using O-methylglycine as a pseudo-substrate to study the 
ALAS-catalyzed reaction. Since the carboxyl group of O-methylglycine is protected against 
decarboxylation, formation of the carbanion intermediate can only proceed by initial 
deprotonation. Moreover, with this pseudo-substrate, the Claisen condensation can still occur, 
yielding the methyl ester of the -ketoacid-aldimine complex, but the reaction cannot proceed 
beyond this step, as the methyl ester of the -amino--ketoacid (or methoxy-4,6-dioxo-hexanoic 
acid) intermediate cannot undergo decarboxylation. Indeed, when we used LC-MS/MS to 
analyze the mALAS2-catalyzed product resulting from the reaction of mALAS2 with O-
methylglycine and succinyl-CoA, a pronounced peak (188.9 m/z) was observed for the molecular 
ion of the putative, more stable, condensation intermediate (Fig. 2.1), in good agreement with its 
predicted molecular weight of 189.17. To verify that the 188.9 m/z peak was due to the 
mALAS2-catalyzed formation of the Claisen intermediate, 5-amino-6-methoxy-4,6-dioxo-
hexanoic acid was synthesized and analyzed using LC-MS/MS. In addition, a shift of +1 m/z was 
apparent when deuterated O-methylglycine was the pseudo-substrate, further validating the 
chemical nature of the condensation intermediate (data not shown). Our findings can probably be 
extended to the reaction mechanism of other α-oxoamine synthases, particularly since it supports 
an earlier report inferring the presence of the AONS-bound methyl ester of the condensation 
intermediate (19).  
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Until this study, detection of the first quinonoid intermediate in the mALAS2 catalytic 
pathway (Scheme 2.1, III) had not been demonstrated. Clearly, the identification of the 
condensation intermediate argues in favor of the first quinonoid (or glycine quinonoid) species 
(Scheme 2.1, III), as this intermediate could only have been formed from deprotonation of the O-
methylglycine pseudo-substrate. In prior transient kinetic studies conducted with mALAS2, 
glycine and succinyl-CoA, it was deduced that the formation and decay of the glycine quinonoid 
intermediate occurred too rapidly to be kinetically significant (13), and was demonstrated that 
the addition of succinyl-CoA accelerated the rate of the reaction of mALAS2 with glycine by 
several orders of magnitude (23). In the present study we reacted mALAS2 with glycine at 18 
oC, instead of 30 oC (13), and monitored the reaction by following the change in absorbance at 
420 nm (Fig. 2.3A) and 510 nm (Fig. 2.3B). The glycine quinonoid intermediate could be 
detected at 510 nm, further supporting the conclusion of the mass spectrometry results that wild-
type mALAS2 catalyzes the abstraction of a proton from glycine. Even though the formation of 
the glycine external aldimine and glycine quinonoid intermediates proceeded at similar rates 
(Figs. 2.3A and 2.3B), in the absence of succinyl-CoA, the external aldimine outweighs the 
quinonoid intermediate. In fact, the amplitude value representing the formation of the initial 
quinonoid intermediate was estimated to be approximately 4% of the amplitude value for the 
same intermediate when produced in the presence of the succinyl-CoA substrate. The 
significantly reduced amplitude value for the formation of the quinonoid intermediate indicates 
that this intermediate, in the absence of succinyl-CoA, is catalyzed by a small percentage of the 
total enzyme population, which can, in part, explain the difficulties associated with the 
spectroscopic detection of the glycine quinonoid intermediate.  
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    Unlike the reaction with glycine, the kinetic trace for the reaction between L-serine and 
wild-type mALAS2 is characterized by a lag phase (Fig. 2.4A). Typically, a lag phase is 
observed in the reaction progress curves of enzymes with hysteretic behavior (36). These 
enzymes undergo conformational changes at a rate that is slower than that of the corresponding 
chemical reaction (36). We propose that structural rearrangements induced by the entry of L-
serine into the ALAS active site precede the formation of the serine-ALAS external aldimine. 
While the specific structural rearrangements induced by L-serine binding remain to be defined, it 
is entirely conceivable that the entry of L-serine into the tightly packed ALAS active site results 
in steric clashes between L-serine and active site amino acids, and the generated conformational 
strain hinders the ability of the enzyme to properly stabilize conformation favorable for catalysis 
of the external aldimine. To provide a compatible interpretation for the orientation of L-serine 
within the active site of ALAS, we modeled the L-serine external aldimine of Sphingomonas 
paucimobilis serine palmitoyltransferase (SPT) in the active site of R. capsulatus ALAS (Fig. 
2.6). These two enzymes belong to the α-oxoamine synthase family and share a conserved fold, 
active site architecture, and catalytic mechanism. Interestingly, there are notable differences in 
the positioning of the α-carboxyl group of the amino acid substrate: the α-carboxyl group of 
glycine forms a salt bridge with R439, while the α-carboxyl group of L-serine is predicted to 
interact with H207 (mALAS2 numbering; R. capsulatus numbering is indicated in Fig. 2.6). 
Hence, during initial binding, L-serine can sterically clash with amino acids in the active site of 
ALAS. The resulting conformational strain might be transient, and, once the external aldimine is 
formed, the enzyme assumes a closed conformation similar to that adopted in the presence of its 
physiological substrates. However, we cannot exclude the possibility that the binding of L-serine 
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stabilizes a catalytically incompetent conformation, distinct from the previously reported open 
and closed conformations (12).  
 
 
Figure 2.6. Model depicting the positioning of the L-serine external aldimine in the active site of 
ALAS. The model was created by superimposing the L-serine external aldimine of S. paucimobilis SPT 
(PDB file 2W8J) with the glycine external aldimine of R. capsulatus ALAS (PDB file 2BWP). L-serine is 
shown in green and glycine in cyan. Succinyl-CoA was subsequently modeled into the active site by 
superimposing the generated structure with the structure for the R. capsulatus●succinyl-CoA complex 
(PDB file 2BWO), using PyMOL. R. capsulatus ALAS amino acids T83, H142, K248 and R374 
correspond to mALAS2 T148, H207, K313 and R439, respectively 
 
   One amino acid within the active site of mALAS2 that can come to steric clashes with L-
serine is T148. This amino acid modulates the amino acid substrate specificity of mALAS2, such 
that its substitution with alanine endows the T148A variant with the capacity to utilize L-serine 
as substrate (data not shown). According to our structural model, once the external aldimine is 
formed, the L-serine α-carboxylate is about 2 Å apart from the T148 side chain methyl group 
(Fig. 2.6). This orientation differs from that of the α-carboxylate of the glycine external aldimine, 
which is oriented away from T148. Consequently, L-serine, by not orienting properly in the 
active site of mALAS2, clashes with T148 during the formation of the external aldimine. This 
hypothesis is supported by the absence of a lag phase in the progress curve for the T148A-
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catalyzed serine external aldimine formation (Fig. 2.4B). The considerably smaller side chain of 
alanine than of threonine provides a more open active site pocket in the T148A variant than in 
wild-type mALAS2. Thus, in contrast to wild-type mALAS2, not only can L-serine be properly 
oriented and succinyl-CoA accommodated, but also the condensation reaction can take place in 
the active site of the T148A variant.  
While the formation of the Ser-mALAS2 external aldimine was easily followed (Fig. 
2.4A), the activity of mALAS2 with serine and succinyl-CoA could not be determined under 
steady-state conditions (data not shown), as monitored by CoA production (37). These findings 
indicate that the mALAS2-catalyzed condensation between L-serine and succinyl-CoA does not 
proceed beyond external aldimine formation and suggest that succinyl-CoA fails to bind 
productively to the active site, as evident from the absence of detectable CoA production. The 
inability of succinyl-CoA to bind productively in the presence of L-serine probably stems from 
the positioning of L-serine, whose α-carboxyl group is oriented differently from that of glycine 
(Fig. 2.6). For the reaction between the amino acid substrate and succinyl-CoA to occur, the 
former needs to interact with R439, as demonstrated with glycine (38). In the case of L-serine, 
our model predicts that its α-carboxyl group interacts with H207 rather than R439, which in turn 
would hamper the binding of succinyl-CoA due to steric clashes between the succinyl moiety 
and the α-carboxyl group of L-serine (Fig. 2.6). Therefore, the interaction between the α-
carboxyl group of the amino acid substrate and R439 is important for proper positioning of 
succinyl-CoA into the active site. This is supported by data demonstrating that the conservative 
mutation R439K results in a 20-fold decrease in the catalytic efficiency for succinyl-CoA, while 
the R439L mutation is deleterious, implying that R439 has an important role in facilitating 
productive binding of the substrates (38). 
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     The rate-limiting step in the ALAS-catalyzed reaction has been assigned to a 
conformational change resulting from the reversion of the enzyme to the open conformation 
during the release of ALA (14, 23).  Characterization of the reaction with ALA revealed a lag 
phase in the kinetic trace of the external aldimine formation (Fig. 2.5A), implying that the entry 
of ALA in the active site induces potential conformational rearrangements. Since the ALA-
external aldimine (Scheme 2.1, VIII) is the final intermediate in the reaction pathway, it would 
be interesting to examine in future studies whether its formation, or more likely, the dissociation 
of ALA from PLP, induces conformational rearrangements within the active site that can 
destabilize the closed conformation and facilitate reversion to the open conformation, resulting in 
the release of ALA from the enzyme. 
   Upon close examination of the crystal structure of R. capsulatus ALAS, we identified an 
alternative access channel to the active site, which possibly provides the path for entry of glycine 
or exit of ALA (Fig. 2.7). This channel, distinct from that occupied by succinyl-CoA, can only 
be seen in the open conformation structures. It covers amino acids from the N-terminal domain, 
organized in an -helix and a loop (i.e., R. capsulatus ALAS amino acids 1-24) and amino acids 
from the C-terminal domain making an -helix and a linker (i.e., R. capsulatus ALAS amino 
acids 337-352). The active site glycine-rich loop (i.e., R. capsulatus ALAS amino acids 77-89) 
from the opposite monomer also contributes to the architecture of this channel. Val-341 and Gly-
18, located approximately 10Å apart and in the open conformation, outline the entry of the 
channel (Fig. 2.8). Actually, the active site loop and the C-terminal helix make up a structural 
region in R. capsulatus ALAS that undergoes significant conformational changes during the 
conversion from open to closed conformation (Fig. 2.8).  
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      X-linked sideroblastic anemia mutations localized to the human ALAS2 N-terminal -
helix and loop also led us to suggest a physiological relevance to this structural region of the 
channel. These mutations [M154I, D159N, D159Y, T161A, and F165L (4, 12)] may perturb the 
structural integrity of the channel and obstruct the entry of glycine to or ALA exit from the 
active site. If a protein transporter, as recently suggested for the human SLC25A38 gene product 
(39), is involved in the import of glycine to or the export of ALA from mitochondria, then it will 
be important to examine whether the SLC25A38 transporter interacts with ALAS and whether 
the channel amino acids participate in the protein-protein interactions. 
 
 
 
 
Figure 2.7. Alternative channel for the entry of substrates into the active site of R. capsulatus 
ALAS. (A) The alternative channel in the open and (B) closed conformations (PDB files 2BWN and 
2BWO). This channel and the succinyl-CoA-specific channel are distinct. The N-terminal domain is 
shown in cyan, the catalytic domain in gray and the C-terminal domain in magenta. The opposite 
monomer is shown in yellow. Succinyl-CoA is shown in stick representation 
 
 
 
 
 
 
53 
 
 
 
 
 
Figure 2.8. Differences in the positioning of C-terminal α-helix Val-341 in the open and closed 
conformations.  The open and closed conformations are shown in gray and cyan, respectively. 
Monomers A and B (PDB file 2BWN) were superimposed using PyMOL. 
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Chapter Three 
 
Asn-150 of murine erythroid 5-aminolevulinate synthase is important in favoring the 
catalytic balance toward 5-aminolevulinate formation over its non-productive 
transformation into the quinonoid intermediate 
 
 
Abstract 
5-Aminolevulinate synthase (ALAS) catalyzes the first step in mammalian heme 
biosynthesis, the pyridoxal 5’-phosphate (PLP)-dependent and reversible reaction between 
glycine and succinyl-CoA to generate CoA, CO2, and 5-aminolevulinate (ALA). In Rhodobacter 
capsulatus ALAS, apart from coordinating the positioning of succinyl-CoA, N85 has an 
important role in regulating the opening of an active site channel. Here, we mutated the 
analogous asparagine of murine erythroid ALAS to histidine (N150H) and assessed the effects of 
this mutation on catalysis using steady-state and transient kinetic studies. Quinonoid intermediate 
formation occurred with a significantly reduced rate for the N150H-catalyzed condensation of 
glycine with succinyl-CoA during a single turnover. When the same forward reaction was 
examined under multiple turnovers, the progress curve of the N150H reaction displayed a 
prolonged decay of the quinonoid intermediate into the steady-state, distinct from the steep decay 
in the wild-type ALAS reaction. This prolonged decay results from an accelerated transformation 
of the product, ALA, into the quinonoid intermediate during the reverse N150H-catalyzed 
reaction. In fact, while wild-type ALAS catalyzes the conversion of ALA into the quinonoid 
intermediate at a rate 6.3-fold lower than the formation of the same quinonoid intermediate from 
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glycine and succinyl-CoA, the rate for the N150H-catalyzed reverse reaction is 1.7-fold higher 
than that of the forward reaction. We conclude that N150 is important in establishing a catalytic 
balance between the forward and reverse reactions, by favoring ALA synthesis over its non-
productive transformation into the quinonoid intermediate. Mutations at this position could 
perturb the delicate heme biosynthetic equilibrium.  
 
Introduction 
5-Aminolevulinate synthase (ALAS), a homodimeric, pyridoxal 5’-phosphate (PLP) 
dependent enzyme, catalyzes the first and regulatory step in mammalian heme biosynthesis, 
which is the condensation between glycine and succinyl-CoA to generate coenzyme A (CoA), 
CO2, and 5-aminolevulinate (ALA) (1, 2). Loss-of-function and gain-of-function mutations in the 
erythroid-specific ALAS gene (ALAS2) result in X-linked sideroblastic anemia (XLSA) and X-
linked dominant protoporphyria (XLDPP), respectively (3, 4), suggesting that the rate of ALA 
synthesis is a closely regulated physiological process, ultimately ensuring that heme production 
meets the requirements of developing erythroid cells during hemoglobinization, while averting 
disturbances in porphyrin and iron metabolism that can result in cellular toxicity 
The rate-limiting step of the ALAS-catalyzed reaction has been assigned to a closed-to-
open conformational transition that coincides with ALA release from the active site (5-7). During 
this conformational transition, the active site becomes more accessible to the solvent as a result 
of segmental motions associated with the repositioning of an active site loop and a C-terminal 
helix (8). Mutations in the flexible active site loop can increase the kcat by 30-fold and the 
catalytic efficiency for succinyl-CoA by about 100-fold (9), implicating that wild-type ALAS 
evolved away from catalytic power, which was probably an evolutionary necessity to minimize 
62 
 
toxic build-up of highly reactive ALA-derived porphyric intermediates. This necessity is further 
substantiated with results indicating that even subtle increases in the catalytic activity as a result 
of mutations in the human ALAS2 gene can lead to the erythropoietic disorder XLDPP (4, 10). 
Moreover, in order to avert the toxic accumulation of free mitochondrial iron that ensues with 
inadequate ALA biosynthesis, an equally important evolutionary pressure must have shaped the 
active site architecture of ALAS to minimize undesirable side reactions that could otherwise 
inactivate the enzyme or generate products other than ALA. Two pieces of evidence supporting 
this argument include: 1) the inefficacy of ALAS in catalyzing the abstraction of the pro-R 
proton of glycine in the absence of succinyl-CoA (5, 6, 11), which eventually could result in 
enzyme inactivation through abortive transamination, and 2) the strict substrate specificity of 
ALAS toward glycine as the only reported natural amino acid condensing with succinyl-CoA 
(11-13) (thus, minimizing the biosynthesis of products other than ALA). This specificity is 
abolished upon mutating an invariant threonine present in an active site glycine-rich stretch, 
suggesting that this region is important in defining the reaction selectivity (11-13). Furthermore, 
because the ALAS-catalyzed reaction is reversible (14), catalytic balance between the forward 
and reverse reactions must be in place to ensure that physiologically relevant concentrations of 
ALA are available for unperturbed heme biosynthesis. 
The postulated reaction mechanism for the ALAS-catalyzed reaction is shown in scheme 
3.1. Two carbanions, termed quinonoid intermediates (λmax~510 nm), are generated during the 
ALAS catalytic cycle for the condensation of glycine and succinyl-CoA (5-7, 11, 12, 14, 15).  
An initial quinonoid intermediate is formed upon removal of the pro-R proton from the glycine-
external aldimine complex (Scheme 3.1, III) (11, 12, 14), while a second quinonoid intermediate 
(henceforth referred as quinonoid intermediate II [Scheme 3.1, VII]) results from the 
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decarboxylation of the 2-amino-3-ketoadipate condensation intermediate (5-7). The generated 
enol, which is in rapid equilibrium with the quinonoid intermediate II, is then protonated to yield 
the ALA-external aldimine (Scheme 3.1 , VIII) (7). Release of ALA from the active site, guided 
by conformational transitions, represents the final step of the catalytic cycle. Since the stable 
quinonoid intermediate II is also generated upon removal of the C5 proton of ALA during the 
reverse reaction (5, 6, 11, 15), the active site of ALAS must have evolved to minimize the non-
productive transformation of ALA into the quinonoid intermediate II. However, the active site 
region responsible for minimizing this non-productive transformation remains unknown. 
 
 
Scheme 3.1. Postulated mechanistic cycle for the catalytic events in the active site of mALAS2. (I)  
Internal aldimine complex, (II) glycine-external aldimine, (III) quinonoid intermediate I, (IV) glycine-
succinyl-CoA condensation intermediate, (V) 2-amino-3-ketoadipate intermediate, (VI) enol intermediate, 
(VII) quinonoid intermediate II, (VIII) ALA-external aldimine. 
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Recently, we have identified an alternative channel in Rhodobacter capsulatus ALAS 
that serves as a potential path of entry for glycine to and ALA exit from the active site (Fig. 3.1) 
(11). The architecture of this channel is shaped by amino acids from the C-terminal (i.e., R. 
capsulatus ALAS amino acids 337-352) and N-terminal (i.e., R. capsulatus ALAS amino acids 
1-24) domains of one monomer and by the glycine-rich stretch from the opposite monomer (i.e., 
R. capsulatus ALAS amino acids 77’-89’) (Fig. 3.1), which is important in defining the amino 
acid substrate specificity. N85’ (N150’ of murine erythroid ALAS [abbreviated as mALAS2]) of 
this glycine-rich stretch appears to play a particularly important role in mediating the opening 
and closing of this channel. Upon careful analysis of the crystal structure of R. capsulatus ALAS 
(8), we observed that, in the closed conformation, N85’ forms an H-bond with Q359 (Q424 of 
mALAS2) of the flexible active site loop, resulting in closure of the channel (Figs. 3.1 and 3.2). 
When ALAS reverts to the open conformation, this interaction is disrupted, and the side chain of 
N85’ is reoriented away from the active site loop, which, in turn, results in opening of the 
channel (Fig. 3.2). Apart from gating the active site from the solvent, N85’ plays a vital role in 
positioning the carboxyl group of succinyl-CoA (8, 12), thus ensuring that the carbonyl group of 
this substrate and the C-α of the glycine-external aldimine attain an orientation favorable for 
condensation. Moreover, once condensation occurs, the succinyl-derived carboxyl group of the 
resulting 2-amino-3-ketoadipate intermediate is expected to retain the interaction with N85’, 
implicating an additional role of this amino acid in catalytic steps subsequent to condensation 
(i.e., in reaction steps after IV of Scheme 3.1.). 
Based on the postulated catalytic importance of this invariant asparagine, we have 
performed extensive kinetic and equilibrium studies to assess the effects on catalysis that ensue 
upon substituting N150’ of mALAS2 with a histidine. The data reveal that N150’ is essential in 
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establishing a catalytic balance between the forward and reverse reactions by favoring ALA 
synthesis over its non-productive transformation into the quinonoid intermediate II.  
 
 
 
Figure 3.1. Alternative channel leading to the active site of R. capsulatus ALAS in the open (A) and 
closed (B) conformations. In the closed conformation, the repositioning of the side chain of N85’ (yellow 
sticks) results in closure of the channel. The N-terminal domain is shown in cyan, the catalytic domain in 
gray, and the C-terminal domain in magenta, while the opposite monomer is shown in yellow. The image 
was created by aligning the A and B monomers of PDB file 2BWN with those of 2BWO using PyMOL. 
 
 
 
 
Figure 3.2. The side chain of N85’ becomes reoriented during the closed (cyan) to open (gray) 
conformational transition in R. capsulatus ALAS. Only in the closed conformation does N85’ form an 
H-bond with Q359 of the flexible active site loop. N85’ in R. capsulatus ALAS corresponds to N150’ in 
mALAS2. The image was created by aligning the A and B monomers of PDB file 2BWN with those of 
2BWO using PyMOL. 
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Materials and methods 
 Reagents 
  The following reagents were obtained from Fisher Scientific: glycine, potassium 
phosphate monobasic, potassium phosphate dibasic, HEPES, glycerol, and sodium hydroxide. A 
bicinchoninic acid assay kit was from Thermo Scientific. 5-Aminolevulinate hydrochloride was 
from Acros Organics, and pyridoxal 5’-phosphate, bovine serum albumin (BSA) standards, 
DEAE resin, and ACA-44 ultrogel were from Sigma-Aldrich. 
 
 Construction and isolation of the N150H variant  
  The N150H variant was obtained by screening a library of mALAS2 variants for ALAS 
activity as described previously for the T148A variant (11). 
 
 Overproduction and purification of wild-type mALAS2 and variant enzymes 
  Wild-type mALAS2 and the variant enzyme were overproduced and purified as 
previously described (16). All purification steps subsequent to cell lysis were performed in one 
day, and the concentrated proteins were stored under liquid nitrogen for further use. Protein 
purity was assessed by SDS-PAGE, and all enzymes were purified to homogeneity. The protein 
concentration of the enzymes used for steady-state kinetic analyses was determined by the 
bicinchoninic acid-based assay using BSA as standard and measuring the absorbance of each 
sample and standard at 532 nm after incubation at 37 ºC for 30 minutes as described in the 
protocol supplemented by the manufacturer (thermo scientific). Protein concentration of 
enzymes used in pre-steady state kinetic analyses was determined spectroscopically from the 
absorbance at 280 nm and using an extinction coefficient of 42860 M-1·cm-1 based on the 
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mALAS2 amino acid sequence.  All protein concentrations are reported according to a subunit 
molecular mass of 56,000 Da. 
 
 Steady-state kinetics  
Steady-state activities of the wild-type mALAS2 and N150H enzymes were determined 
using a continuous spectrophotometric assay (17).  All assays were performed in 20 mM HEPES, 
pH 7.5, containing 10 % glycerol and at 37 ºC and monitored with a Shimadzu UV-2401 PC 
spectrophotometer. The pertinent final concentrations in the assays were 2 µM enzyme (wild-
type mALAS2 or variant), 5-200 mM glycine and 0.5-20 M succinyl-CoA. The steady-state 
kinetic parameters (kcat and Km) were calculated by fitting the data, collected as matrixes of five 
glycine and five succinyl-CoA concentrations, to the Michaelis-Menten equation (Eq. 3.1) using 
non-linear regression analysis (Sigma-plot software). 
                                                                ݒ ൌ ௏೘ೌೣሾௌሿ௄೘ାሾௌሿ                               Eq. 3.1 
                                                                                                    
 Equilibrium dissociation constants for succinyl-CoA and CoA 
  Equilibrium dissociation constants for succinyl-CoA or CoA were determined by titrating 
each of the enzymes (wild-type or N150H) with increasing concentrations of ligand and 
monitoring the quenching of intrinsic fluorescence at 340 nm upon excitation at 280 nm. The 
titration experiments were performed at 37 ºC and pH 7.5 and monitored using a Shimadzu 
RF5301 PC spectrofluorophotometer. Briefly, 1 µM of enzyme in 20 mM HEPES, pH 7.5, 
containing 10 % glycerol, was titrated with small aliquots of increasing concentrations of 
succinyl-CoA or CoA (from a 24 mM stock) while stirring, until no further change in 
fluorescence emission was observed. The addition of ligand did not result in significant changes 
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in the reaction volume (~4 % change in the final volume) and it did not affect the pH of the 
buffer. The protein and ligands were equilibrated within the cell for 1 minute prior to collecting 
the spectra. In order to obtain the fraction of ligand bound (F.B) to the enzyme, data were 
normalized using equation 3.2,  
                                                               F. B. ൌ ௫ି௫೔௫೑ି௫೔                                 Eq. 3.2 
where x represents the maximal fluorescence emission at specific ligand concentration, xi is the 
emission in the absence of ligands, and xf is the emission at the highest concentration of ligand 
when the enzyme was fully saturated. The equilibrium dissociation constant, Kd, was determined 
by fitting the data to equation 3.3, using SigmaPlot software for the non-linear regression 
analyses.  
                                                                 ܻ ൌ ௒ౣ ౗౮ሾௌሿ௄ౚାሾௌሿ                                   Eq. 3.3 
 
 Pre-steady state kinetics  
   Reactions between the enzyme (mALAS2 or variant)-glycine complex and succinyl-CoA 
were analyzed using transient kinetics. Upon rapid mixing of the enzyme-glycine complex with 
succinyl-CoA, single-wavelength spectra were collected at 510 nm on a KinTek stopped-flow 
spectrophotometer (model SF-2001). All reactions were performed at 18 ºC using a buffer 
composed of 50 mM phosphate, pH 7.5 (37 mM K2HPO4/13 mM KH2PO4) and 10 % glycerol 
(v/v).  For reactions under single turnover conditions, with the enzyme molar concentration in 
excess over that of succinyl-CoA, one of the syringes contained 120 µM enzyme (either wild-
type mALAS2 or variant) and 200 mM glycine in the above described buffer, while the other 
syringe contained 40 µM succinyl-CoA in the same buffer. The concentrations of reactants in the 
observation cell were one-half of those in the syringes. For reactions conducted under multiple 
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turnover conditions, with succinyl-CoA in excess over enzyme, one of the syringes contained 60 
µM enzyme (either wild-type mALAS2 or variant) and 200 mM glycine in the above phosphate 
buffer, whereas the other syringe contained excess succinyl-CoA in the same buffer. Using the 
KinTek stopped-flow software, the time course data were fitted to either a two- or three-
exponential equation (Eq. 3.4), 
                           	
ܣ ൌ ෍ܽ௜݁ି௞೔௧ ൅ 	ܿ
ଷ
௡ୀଵ
 
                                                                                                                          Eq. 3.4 
where At is the absorbance at time t, a is the amplitude of each phase, k is the observed rate 
constant for each phase and c is the final absorbance. The reaction between wild-type mALAS2 
or variant enzyme and ALA was also examined using transients by monitoring the change in 
absorbance at 510 nm upon rapid mixing of the reactants. One of the syringes contained 60 µM 
enzyme in the above 50 mM phosphate buffer, while the other syringe contained ALA in the 
same buffer. Prior to reacting mALAS2 (or the N150H variant) with ALA, the ALA-HCl stock 
was neutralized in equal molar concentration of NaOH. This was accomplished by creating 2-
fold serial dilutions of ALA and NaOH, where the final concentration of ALA in the observation 
chamber, neutralized in equal molar concentration of NaOH, varied from 0.5 to 30 mM. Once 
the reaction was completed, it was verified that the pH in the syringe was 7.5. The dependence of 
the observed pseudo-first order rate constants on the concentration of ALA were fitted to an 
equation describing a two-step reaction (Eq. 3.5), using non-linear regression analyses (Sigma-
plot software). 
                                                     ݇୭ୠୱ ൌ ௞౥౤ሾௌሿ௄ౚାሾௌሿ ൅ ݇୭୤୤                               Eq. 3.5 
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Results 
 Steady-state kinetics and specificity constants 
  The steady-state kinetic parameters and specificity constants for wild-type mALAS2 and 
the N150H variant were determined at 37 °C and pH 7.5 (Table 3.1). The mutation resulted in a 
50 % decrease in the kcat value, with no changes in ܭ୫ୗେ୭୅ , and only a modest increase in the 
ܭ୫ୋ୪୷. Interestingly, the kcat reported here for mALAS2 without a His-tag is about ~3-fold lower 
than the one reported by Tan et al. (18) under identical conditions for the enzyme with an N-
terminal His-tag. However, in that study, the enzyme concentration was estimated using a BCA-
based assay after the protein was precipitated with acetone (18, 19). We validated that acetone 
precipitation can underestimate the protein concentration (data not shown), and thus, the 
disparities in the reported kcat values largely result from differences in the methods used to 
quantify the protein concentration, and not from the presence of a His-tag. 
 
  
 Equilibrium dissociation constants for succinyl-CoA and CoA 
  The equilibrium dissociation constant (Kd) values for succinyl-CoA and CoA were 
determined at 37 °C and pH 7.5 by monitoring the quenching in intrinsic protein fluorescence 
upon titration of the wild-type enzyme or the N150H variant with increasing concentrations of 
ligand (Fig. 3.3). Wild-type mALAS2 exhibited equal binding affinity toward succinyl-CoA and 
CoA, implying that binding is primarily facilitated by the CoA moiety (Table 3.2). Moreover, the 
Table 3.1  
Steady-State Kinetic Parameters and Specificity Constants  
Enzyme kcat 
(s-1) 
K Glym  
(mM) 
K SCoAm
 
(µM) 
kcat / K
Gly
m
 
(s-1.mM-1) 
kcat / K
SCoA
m
 
(s-1.µM-1) 
wt mALAS2 0.19±0.01 18±3 1.3±0.3 11 x10-3±2 x10-3 146 x10-3±41 x10-3 
N150H 0.09±0.002 32±4 1.2±0.2 2.8 x10-3±0.4 x10-3 75 x10-3±14 x10-3 
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wild-type and N150H enzymes have identical KdSCoA values within error, while the N150H 
variant displayed weaker binding toward CoA (Table 3.2). Since CoA lacks a succinyl moiety, 
the results suggest an important role for the succinyl moiety in the binding of succinyl-CoA to 
the active site of the N150H variant. Interestingly, there are notable differences between the Km 
and Kd values for succinyl-CoA (Tables 3.1 and 3.2). For the wild-type enzyme, the Kd value is 
about 230-fold greater than the Km value. These findings imply that KmSCoA  does not represent a 
measure of substrate affinity analogous to the k-1/k1 term, which describes the Kd (with k-1 and k1 
representing the rate constants associated with the dissociation and association of succinyl-CoA 
to mALAS2, respectively), but rather it represents a complex kinetic function of all the rate 
constants in the pathway. 
 
Figure 3.3. Binding isotherms for the association of succinyl-CoA or CoA with wild type mALAS2 
or the N150H variant enzyme.  Titration of (A) wild-type mALAS2 and (B) N150H with increasing 
concentration of succinyl-CoA; titration of (C) wild-type mALAS2 and (D) N150H with increasing 
concentrations of CoA. All reactions were done in duplicates and the error bars are covered with the 
symbols. 
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 Single-turnover experiments 
  Pre-steady state reactions between the enzyme-glycine complex and succinyl-CoA were 
conducted under single turnover conditions, with enzyme concentrations in excess over those of 
succinyl-CoA, and followed by monitoring the changes in absorbance at 510 nm that result from 
the formation of the quinonoid intermediate II (Fig. 3.4, [Scheme 3.1, VII]). Because of the rapid 
formation and transient nature of the quinonoid intermediate II, it was challenging to accurately 
discern the individual kinetic phases at 37 °C, and consequently, the reaction was monitored at 
18 °C and pH 7.5. The reactions for either the wild-type or variant enzymes are best described by 
a three-exponential process (Fig. 3.4). Previous extensive single-turnover experiments with 
mALAS2 have led to the assignment of the three kinetic steps to 1) generation of the quinonoid 
intermediate II upon decarboxylation of the 2-amino-3-ketoadipate intermediate, 2) decay of this 
quinonoid intermediate, as facilitated by protonation of the enol by K313, and 3) conformational 
rearrangement of the enzyme to induce ALA release from the active site (Scheme 3.1) (7).  
Presented in table 3.3 are the three observed rate constants for the reactions catalyzed by the 
wild-type and variant enzymes. A significant decrease in the rate of formation of the quinonoid 
intermediate II was detected for the N150H-catalyzed reaction, with an observed rate constant  
k1 = 0.81 ± 0.02 s-1. This rate is by 79 % lower than that of the wild-type enzyme, while 
decreases of 73 % and 47 % were detected for the rates of quinonoid decay (k2) and ALA release 
Table 3.2 
Equilibrium dissociation constants for Succinyl-CoA 
and CoA  
Enzyme ܭୗୢେ୭୅ 
µM 
ܭେୢ୭୅ 
µM 
wt mALAS2       297 ± 7 302 ± 12 
N150H  281 ± 7 495 ± 25 
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(k3), respectively (Table 3.3). These data implicate an important role for N150 in catalysis, 
probably by stabilizing the positioning of the condensation intermediate in an orientation that is 
favorable for decarboxylation. 
 
 
Figure 3.4. Kinetic traces of the reactions of enzyme (wild-type mALAS2 or N150H)-glycine 
complex with succinyl-CoA under single turnover conditions. The kinetic traces for the reactions of 
(A) wild-type mALAS2-glycine and (B) N150H-glycine complexes with 20 µM succinyl-CoA (purple 
circles), as followed by monitoring the changes in the quinonoid intermediate absorbance at 510 nm, were 
overlaid with the lines (black) calculated from the data fitting to equation 3.4 for a three-exponential 
process. The reported succinyl-CoA concentration is that in the observation chamber. 
 
 
 
 
 
 
 
 
Table 3.3 
Observed rate constants for the reaction between the enzyme-glycine complex 
and succinyl-CoA  
Enzyme k1 
s-1 
k2 
s-1                 
k3 
s-1 
wt mALAS2       3.8 ± 0.03 0.59 ± 0.005 0.038 ± 0.001 
N150H     0.81± 0.02 0.16 ± 0.002 0.020 ± 0.001 
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 Multiple turnover experiments 
  The transient reaction between the enzyme-glycine complex and succinyl-CoA, 
monitored by following the absorbance changes at 510 nm, was also conducted under multiple 
turnover conditions (18 °C and pH 7.5), with succinyl-CoA concentration in excess over those of 
the enzyme. While the reactions catalyzed by the wild-type enzyme were best described by a 
biphasic process, corresponding to the formation of the quinonoid intermediate II followed by its 
steep decay into the steady-state (Fig. 3.5A-C), the progress curves of the N150H variant-
catalyzed reactions displayed an apparent, prolonged decay of the quinonoid intermediate II into 
the steady-state (Fig. 3.5D-F). This precluded us from fitting the data for the N150H-catalyzed 
reactions to a two-exponential equation, without significant residual error (data not shown). 
Lowering the succinyl-CoA concentration in the N150H-catalyzed reaction resulted in a more 
rapid decay of the quinonoid intermediate II, implying a potential accumulation of reaction 
intermediates absorbing at the wavelength of interest (Fig. 3.5). Of note, in some reactions (see 
Fig. 3.5 legend), we violated the multi-turnover premise by lowering the succinyl-CoA 
concentration to 30 μM with the aim of showing that the decay of the kinetic trace displayed 
dependence on the concentration of succinyl-CoA. 
 
 Reaction of ALA with either wild-type mALAS2 or N150H  
  Since the kinetic trace for the multi-turnover reaction of the N150H-glycine complex 
with succinyl-CoA revealed a prolonged decay of the quinonoid intermediate II into the steady-
state (Fig. 3.5), which  may have resulted from accumulation and transformation of ALA back 
into the quinonoid intermediate II (Scheme 3.1), we set to examine the mALAS2- and N150H-
catalyzed reverse reactions. Previously, we demonstrated that binding of ALA to ALAS is 
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followed by the formation of a stable quinonoid intermediate (Scheme 3.1, VII) with a 
characteristic absorbance maximum at 510 nm (5, 6). Thus, the reverse-catalyzed reactions 
leading to the quinonoid intermediate II production were examined after reacting ALA with 
either wild-type mALAS2 or N150H, at 18 °C and pH 7.5, by monitoring the absorbance at 510 
nm with stopped-flow spectroscopy. A biphasic process describes the time courses for either of 
the two enzyme reactions with ALA (Fig. 3.6A and B). In agreement with previous studies (5, 
6), the observed rate for the second and slow phase of the wild-type mALAS2 reaction was 
independent of the ALA concentration, while the fast phase rate displayed a hyperbolic 
dependence on ALA concentration (Fig. 3.6C). 
 
 
Figure 3.5. Kinetic traces of the reactions of enzyme (wild-type mALAS2 or N150H)-glycine 
complex with succinyl-CoA under multiple turnover conditions. Progress curves, as monitored from 
the changes in absorbance at 510 nm, were collected for the reactions between the wild-type mALAS2-
glycine complex and (A) 30 µM, (B) 80 µM, and (C) 160 µM succinyl-CoA, and for the N150H-glycine 
complex reacted with (D) 30 µM, (E) 80 µM, (F) and 160 µM of succinyl-CoA. The reported 
concentrations of succinyl-CoA are those present in the observation chamber. In A-C, once the 
absorbance reached a plateau, there were no fluctuations for the initial 70s (not shown). Where applicable, 
(A-C), the data were fitted to a two-step exponential equation, and data points (purple) are overlaid with 
the fitted line (black). 
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Fitting of the data for the ALA-dependent fast phase rates to equation 3.5 yielded a kon value of 
0.61 ± 0.01 s-1 (Fig. 3.6C). Similarly to the wild-type mALAS2-catalyzed reaction, the observed 
rate for the fast phase of the N150H with ALA reaction reached a plateau with increasing ALA 
concentrations, and the slow phase rate was ALA concentration-independent (Fig. 3.6D). 
Importantly, kon of 1.39±0.07 s-1 was obtained for the fast phase of the N150H catalyzed 
formation of the ALA-quinonoid intermediate, indicating 57 % increase in the reaction rate 
relative to the wild-type enzyme. Interestingly, from the kinetic data fit, we have obtained 
ܭ୅ୢ୐୅	=4.7±1.3 mM for the N150H variant, which is higher than the ܭ୅ୢ୐୅	=2.5±0.2 mM for the 
wild-type enzyme. This indicates less tighter binding of ALA to N150H; however, once bound to 
the active site, the rate for the catalytic transformation of ALA into the quinonoid intermediate is 
increased, possibly by providing active site environment that favors catalysis with ALA and/or 
slowing the release of ALA from the active site. 
 
 
Discussion 
The physiological importance for catalytic precision in the rate of ALA synthesis 
becomes obvious if we consider the overwhelming demand of developing erythroid cells for 
heme during hemoglobinization and their requirement to avert perturbations in porphyrin and 
iron metabolism that can lead to cellular toxicity. In fact, even subtle disturbances in the rate of 
ALA synthesis, due to either loss-of-function or gain-of-function mutations in the ALAS2 gene, 
result in erythropoietic disorders, such as XLSA and XLDPP (3, 4). Therefore, the necessity to 
evolve away from hypoactivity and hyperactivity must have been a defining evolutionary 
pressure in shaping the active site of ALAS2. Besides the critical need to synthesize ALA at a 
physiologically relevant rate, it can be argued that equally important evolutionary necessities, 
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albeit quite overlooked, were for ALAS to minimize the non-productive transformation of ALA 
and establish a catalytic balance between the forward and reverse reactions. The combination of 
these factors has probably made possible for differentiating erythroid cells to utilize ALA 
predominantly for heme biosynthesis. However, regions of the active site contributing to the 
achievement of this catalytic balance have never been identified prior to this study. 
 
 
Figure 3.6. Reactions of wild-type mALAS2 or N150H variant with ALA. Progress curves for the 
reactions of 15 mM ALA with (A) wild-type mALAS2 (30 µM), or (B) the N150H variant (30 µM) were 
collected by monitoring the change in absorbance at 510 nm. The data were fitted to a two-exponential 
equation, and the data points (purple) are overlaid with the fitted lines (black). (C) The observed rates for 
the slow phase (filled circles) of the wild-type mALAS2 reaction displayed no dependence on the 
concentration of ALA, while the observed rates for the fast phase (clear circles) exhibited a hyperbolic 
dependence on ALA, yielding kon = 0.61 ± 0.01 s-1;   koff = 0.16 ± 0.01 s-1; = 2.5 ± 0.2 mM. (D) 
Similarly, upon reaction with ALA, the slow phase (filled circles) for the N150H reaction displayed no 
dependence on ALA concentration, while the fast phase (clear circles) exhibited hyperbolic dependence, 
resulting in kon= 1.39 ± 0.07 s-1; koff= 0.03 ± 0.07 s-1; = 4.7±1.3 mM. All reactions shown in C and D 
were done in triplicates, and the error bars are shown beneath the symbols. 
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Structural analysis of R. capsulatus ALAS revealed essential roles for N85 (N150 of 
mALAS2) in both gating the alternative active site channel (Fig. 3.1), and coordinating the 
positioning of succinyl-CoA and the condensation intermediate. Based on these observations, we 
have examined the role of mALAS2 N150 in catalysis by substituting this amino acid with a 
histidine and performing detailed kinetic and equilibrium studies. Comparison of the steady-state 
kinetic parameters for the N150H variant with those for the wild-type enzyme indicated that the 
mutation resulted in a 50% decrease in the kcat value (Table 3.1). Even though N150 coordinates 
the positioning of succinyl-CoA, no changes in the ܭ୫ୗେ୭୅ value were detected with the N150H 
mutation. Moreover, the binding affinity toward succinyl-CoA was not perturbed by this 
mutation, since the Kd value of the variant was identical with that of wild-type mALAS2 (Table 
3.2).  However, the binding of CoA to the variant was weaker than to wild-type mALAS2, 
although in the absence of structural information, it is difficult to rationalize how the N150H 
mutation weakens the affinity, particularly since N150 interacts with the succinyl rather than the 
CoA moiety. It is possible that the mutation indirectly disturbs the integrity of the CoA binding 
site. Interestingly, the binding of succinyl-CoA to the wild-type enzyme is primarily facilitated 
by the CoA, not the succinyl-moiety, as evident from the identical Kd values for succinyl-CoA 
and CoA (Table 3.2.).  
Our study further revealed that the equilibrium dissociation constant, ܭୗୢେ୭୅, which 
reflects the binding affinity of the enzyme toward succinyl-CoA, differs significantly from the 
Michaelis constant,	ܭ୫ୗେ୭୅	— a constant that describes the ligand concentration at which V 
equals ½ Vmax. The Michaelis constant is often misinterpreted for the dissociation constant, 
although the two constants may, or more likely, may not be equal to each other (20). In the case 
of wild-type ALAS, the	ܭୗୢେ୭୅ value is about 230-fold greater than the	ܭ୫ୗେ୭୅	 (Tables 3.1 and 
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3.2). These data indicate that 	ܭ୫ୗେ୭୅	does not represent a measure of substrate affinity analogous 
to the k-1/k1 term, which describes the Kd, but rather it represents a complex, kinetic function of 
multiple rate constants in the pathway. The complexity of the Km expression of a reaction 
pathway containing a single intermediate—which is far less complicated than the multi-
intermediate pathway of the ALAS mechanism—has been reported elsewhere (20). 
The significant reductions in the observed pre-steady state rates for the formation (k1) and 
decay (k2) of the quinonoid intermediate II (Scheme 3.1, VII) that ensued when N150 was 
substituted with a histidine strongly implicate a key role for this asparagine in catalysis. In 
comparison to the wild-type enzyme, the N150H-catalyzed reaction between glycine and 
succinyl-CoA, examined during a single turnover, resulted in reductions by 79 % and 73 % in the 
rates of formation and decay of the quinonoid intermediate II, respectively (Table 3.3). Since 
N150 is predicted to interact with the succinyl-derived carboxyl group of the condensation 
intermediate (the 2-amino-3-ketoadipate intermediate [Scheme 3.1, V], which is a precursor of 
the quinonoid intermediate II [Scheme 3.1, VII]), it is plausible that the N150H mutation affects 
the attainment of a catalytically optimal orientation between this intermediate and reactive 
centers, thus resulting in a higher energetic barrier associated with its transformation into the 
quinonoid intermediate II. 
When the formation of the quinonoid intermediate for the N150H catalyzed reaction 
between glycine and succinyl-CoA was examined during multiple turnovers, prolonged decay of 
the quinonoid intermediate into the steady state was observed, which could not be detected for 
the reaction catalyzed by the wild-type enzyme (Fig. 3.5). This prolonged decay of the quinonoid 
intermediate was dependent on the concentration of succinyl-CoA, suggesting potential 
accumulation of other reaction intermediates that absorb at the monitored wavelength. Since in 
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the reverse reaction, upon reacting with the product, ALA, the enzyme catalyzes the formation of 
a stable quinonoid intermediate with an absorbance maximum at 510 nm, we examined the rates 
associated with the formation of this intermediate, and kon=1.39±0.07 s-1 was obtained for the 
fast phase of the N150H catalyzed reaction. This rate constant is by 59 % increased than that of 
the wild-type enzyme (kon=0.61±0.01s-1), indicating that the N150H mutation promotes an 
accelerated transformation of ALA into the quinonoid intermediate. 
Significantly, our results imply that N150 is essential in establishing catalytic balance 
between the forward and reverse reactions of mALAS2 by favoring formation of ALA over its 
non-productive transformation into the quinonoid intermediate. We arrived to this conclusion 
based on the differences that were detected in the rates of quinonoid intermediate formation 
during the forward (i.e., with glycine and succinyl-CoA) and reverse (i.e., with ALA) reactions 
catalyzed by the N150H and wild-type enzymes. In fact, relative to the rate of quinonoid 
intermediate II catalysis in the forward reaction (k1=0.81±0.02 s-1), the N150H variant transforms 
ALA into the quinonoid intermediate at a rate that is 1.7-fold higher (kon=1.39±0.07 s-1). In 
contrast, the magnitude of these rates for the wild-type reactions is strikingly different. The 
difference is such that relative to the rate of quinonoid intermediate II catalysis in the forward 
reaction (k1=3.8±0.03 s-1), in the reverse reaction, wild-type mALAS2 transforms ALA into the 
quinonoid intermediate at a rate that is 6.3-fold lower (kon=0.61±0.01s-1). 
These imbalances in the rates, where the N150H reaction with ALA is accelerated over 
that with glycine and succinyl-CoA, can account for the apparent, prolonged decay of the 
quinonoid intermediate into the steady-state that was detected during multiple turnovers (Fig. 
3.5), implicating that the N150H variant preferentially catalyzes transformation of ALA into the 
quinonoid intermediate over initiating another round of catalysis with its substrates. Therefore, it 
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is evident that evolutionary pressure favored the selection of this invariant asparagine in order to 
endow ALAS with improved catalytic specificity toward the reaction with glycine and succinyl-
CoA. It is possible that during some evolutionary stage, besides the obvious positive selective 
pressure from the substrates, negative selective pressure by ALA also contributed in shaping the 
active site architecture of ALAS, leading to the selection of N150, which in turn was important 
in minimizing reactivity with ALA. This lack of reactivity was necessary to ensure that ALA is 
utilized predominantly for heme biosynthesis rather than for glycine and succinyl-CoA 
production. Moreover, T148 (mALAS2 numbering), which is also part of the glycine-rich stretch 
where N150 is located, was shown to be essential for the specificity of ALAS toward the amino 
acid substrate (11-13), further corroborating the importance of this structural region in defining 
the reaction selectivity. 
The crystal structure of R. capsulatus ALAS indicates that the asparagine (N85’) 
analogous to N150’ of mALAS2 associates with Q359 of the flexible active site loop in the 
closed conformation (Fig. 3.2). During reversion to the open conformation, the interaction is 
disrupted, and the side chain of the asparagine becomes reoriented away from the loop, leading 
to opening of the alternative side channel (Figs. 3.1 and 3.2). Since this asparagine plays an 
important role in the reversion of the enzyme to the open conformation and in effective opening 
of the alternative channel, it is plausible that the N150H mutation interferes with the release of 
ALA from the active site, resulting in the accumulation and transformation of ALA into the 
quinonoid intermediate. An alternative, and not mutually exclusive, possibility for the increased 
reactivity with ALA is that, in comparison to wild-type mALAS2, the active site of N150H 
provides a catalytic environment that lowers the energetic barrier required for the chemical 
transformation of ALA into the quinonoid intermediate. 
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Chapter Four 
 
Catalytically active alkaline molten globular enzyme: Effect of pH and temperature on the 
structural integrity of 5-aminolevulinate synthase3 
 
Abstract 
  5-Aminolevulinate synthase (ALAS), a pyridoxal-5’phosphate (PLP)-dependent enzyme, 
catalyzes the first step of heme biosynthesis in mammals. Circular dichroism (CD) and 
fluorescence spectroscopies were used to examine the effects of pH (1.0-3.0 and 7.5-10.5) and 
temperature (20 and 37 °C) on the structural integrity of ALAS. The secondary structure, as 
deduced from far-UV CD, is mostly resilient to pH and temperature changes. Partial unfolding 
was observed at pH 2.0, but further decreasing pH resulted in acid-induced refolding of the 
secondary structure to nearly native levels. The tertiary structure rigidity, monitored by near-UV 
CD, is lost under acidic and specific alkaline conditions (pH 10.5 and pH 9.5/37 °C), where 
ALAS populates a molten globule state. As the enzyme becomes less structured with increased 
alkalinity, the chiral environment of the internal aldimine is also modified, with a shift from a 
420 nm to 330 nm dichroic band. Under acidic conditions, the PLP cofactor dissociates from 
ALAS. Reaction with 8-anilino-1-naphtalenesulfonic acid corroborates increased exposure of 
hydrophobic clusters in the alkaline and acidic molten globules, although the reaction is more 
pronounced with the latter. Furthermore, quenching the intrinsic fluorescence of ALAS with 
acrylamide at pH 1.0 and 9.5 yielded subtly different dynamic quenching constants. The alkaline 
                                                            
3 Note to reader. This research was originally published in Biochimica et Biophysica Acta Proteins and Proteomics 
(1). (Stojanovski et al. Biochim. Biophys. Acta, 2014, 1844:2145-2154). Reprinted here with permission from 
Elsevier (See Appendix 2).    
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molten globule state of ALAS is catalytically active (pH 9.5/37 °C), although the kcat value is 
significantly decreased. Finally, the binding of 5-aminolevulinate restricts conformational 
fluctuations in the alkaline molten globule.  Overall, our findings prove how the structural 
plasticity of ALAS contributes to reaching a functional enzyme.
 
Introduction 
5-Aminolevulinate synthase (ALAS) catalyzes the condensation between glycine and 
succinyl-CoA to generate CoA, CO2, and ALA (1-3). This reaction represents the first, and 
regulated, step of heme biosynthesis in mammals, and subtle disturbances in the rate of ALA 
formation resulting from either loss-of-function or gain-of-function mutations in the human 
erythroid specific gene, ALAS2, can lead to X-linked sideroblastic anemia and X-linked 
dominant protoporphyria, respectively (4, 5). 
    Murine erythroid ALAS (henceforth abbreviated as mALAS2) is a homodimer with a 
molecular weight of 112 KDa (6). Each of its two active sites is located at the dimeric interface, 
and is composed of amino acids from the individual monomers (7). Pyridoxal 5’-phosphate 
(PLP), which serves as a cofactor during catalysis, is covalently attached to an active site lysine 
(K313 in mALAS2), forming an internal aldimine (8). The absorbance spectrum of mALAS2 in 
the absence of substrates displays maxima at 330 and 420 nm, representing different tautomeric 
species of the internal aldimine (Fig. 1.1) (9). Previously, we assigned the 420 nm-absorbance 
maximum to a ketoenamine species, and we utilized fluorescence spectroscopy to assign the 330 
nm maximum to a substituted aldamine (9). Moreover, positive dichroic bands with maxima at 
approximately 330 and 420 nm are detected in the circular dichroism (CD) spectrum of 
mALAS2 (10, 11), and since PLP by itself is not a chiral molecule (11), the two maxima indicate 
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an equilibrium between two populations of internal aldimine species with different chiral active 
site environments.  
       The catalytic activity of mALAS2, monitored under steady and pre-steady state 
conditions, exhibits dependence on pH (9, 12). Specifically, an increase in alkalinity is 
accompanied by a decrease in the kcat value (9) and a decrease in the pre-steady state rate 
formation of the second quinonoid intermediate (12). Temperature also affects the catalytic 
turnover of mALAS2. In fact, when the temperature changes from 20 to 37 °C, the kcat value is 
increased by 30-fold, as determined using a continuous, coupled, enzymatic assay (13). The 
temperature at which 50% of the enzymatic activity of mALAS2 is lost was determined to be 
55.3 °C (14). Thus far, however, it is not known to what extent pH and temperature affect the 
structural integrity of ALAS. 
       The crystal structure of Rhodobacter capsulatus ALAS (Fig. 4.1) reveals significant 
content of α-helices and β-sheets that fold into three separate and well-defined domains, which 
constitute the tertiary structure of each monomer (15). Two different conformations have been 
observed: open and closed, where the active site of the former conformation is exposed to the 
solvent, while in the latter, the active site is partly protected as a result of segmental, structural 
rearrangements (15). Importantly, both conformations were observed in the native state of the 
holoenzyme (15), suggesting that even in the absence of substrates, interconversion between the 
conformations occurs; however, based on kinetic data, it was inferred that the binding of 
succinyl-CoA accelerates the transition of ALAS to the catalytically competent closed 
conformation (16, 17). Conformational interconversion also dominates the kcat, and the rate 
limiting step of the reaction had been assigned to a transition from the closed to the open 
conformation during dissociation of ALA from the active site (16, 17). 
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Figure 4.1. Crystal structure of R. capsulatus ALAS. The distribution of color indicates: in pink, amino 
acids with ionizable side groups whose theoretical pKa is lower than 5 (i.e., Asp and Glu); in cyan, amino 
acids with ionizable side groups whose theoretical pKa is greater than 5 (i.e., His, Cys, Tyr, Lys, and Arg); 
in yellow, amino acids with hydrophobic side chains (i.e., Ala, Val, Leu, Ile, Trp, Phe, and Met) and in 
white, all other amino acids (i.e., Ser, Thr, Asn, Gln, Pro, and Gly) [PDB 2BWO]. 
 
Therefore, it is evident that a certain level of structural plasticity is important for effective 
catalysis. Yet the question remains to what extent can the structural integrity of ALAS deviate 
from its native state without compromising the catalytic activity. Several enzymes have been 
shown to retain catalytic activity (18-21), even though they assume a partially folded, molten 
globule state: a highly dynamic conformational ensemble, where due to absence of close packing 
in the protein core, the rigidity of the tertiary structure is lost, without significant disruption in 
secondary structure content (22). To our knowledge the list of enzymes includes: circularly 
permuted dihydrofolate reductase (18), double point mutant of nuclease (19), UreG (20), and 
monomeric chorismate mutase (21). Among the aforementioned enzymes, monomeric 
chorismate mutase (21) is of particular interest, because this “molten globule” enzyme, whose 
structure becomes ordered upon ligand binding, retains identical catalytic activity as that of 
natively folded, dimeric chorismate mutase (21). This indicates that catalytic turnover in some 
89 
 
enzymes may remain unperturbed even when the rigidity of the tertiary structure in the absence 
of ligands is disrupted. 
In this study we have examined how pH and temperature affect the structural integrity of 
mALAS2. While the integrity of the secondary structure is resilient to fluctuations in pH and 
temperature within the examined range, the rigidity of the tertiary structure is disrupted under 
specific alkaline and acidic conditions and the enzyme exists in a molten globule state. These 
structural changes proceed with concomitant modification in the chiral active site environment of 
the internal aldimine. Finally, we show that the enzyme retains catalytic activity, albeit reduced, 
in the alkaline molten globule state, as previously and experimentally defined in the absence of 
ligands. To the best of our knowledge, this is the first reported case of a catalytically active 
alkaline molten globular enzyme.  
 
 Materials and methods 
 Reagents  
  Acrylamide, potassium phosphate monobasic, potassium phosphate dibasic, Tris, glycine, 
acetylacetone, and sodium acetate trihydrate were purchased from Fisher. PLP, 8-anilino-1-
naphtalenesulfonic acid (ANS), p-dimethylaminobenzaldehyde, and CAPS were from Sigma-
Aldrich. AMPSO was from MP Biomedicals, and trichloroacetic acid (TCA) and 5-
aminolevulinate hydrochloride were from Acros Organics. 
 
 Overproduction and purification of wild-type mALAS2  
Wild-type mALAS2 was overproduced and purified as described previously (6). All 
purification steps were performed in one day and the purity of the protein was assessed by SDS-
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PAGE. The purified enzyme was concentrated to 12 mg/mL using an Amicon cell with a 30000 
MW cut-off membrane and then dialyzed against 2 L of 50 mM phosphate, pH 7.5, containing 
40 µM PLP. The protein was stored under liquid nitrogen for further use. The monomeric protein 
concentration was determined spectroscopically using an extinction coefficient of 42860 M-1 cm-
1 calculated from its amino acid sequence. 
   
 Circular dichroism measurements 
  CD measurements were collected using a JASCO J-815 spectropolarimeter and a scan 
speed of 20 nm/min at either 20 or 37 ºC. The temperature was regulated using a thermostatically 
controlled cell holder. For the measurements collected in the far-UV region (260-190 nm), the 
concentration of protein was 0.15 mg/ml and a cell with a 0.1 cm path length was used. The 
measurements were conducted at different pH values using the following buffers: 20 mM 
KH2PO4, pH 1.0, 20 mM KH2PO4, pH 2.0, 20 mM citrate, pH 3.0 (16.7 mM citrate dihydrate and 
3.3 mM sodium citrate dihydrate), 20 mM phosphate, pH 7.5 (16 mM K2HPO4 and 4 mM 
KH2PO4), 20 mM TRIS, pH 8.5, 20 mM AMPSO, pH 9.5 and 20 mM CAPS, pH 10.5. The pH 
of the buffers was adjusted either with hydrochloric acid or sodium hydroxide. Each reported 
measurement in the far-UV region represents the average of four accumulated spectra.  
Protein concentration of 1 mg/mL and a cell with a 1 cm path length was used for the 
measurements in the near-UV / visible region (500-260 nm), which were conducted in identical 
buffers as those used for the measurements in the far-UV region. The total volume in the cell was 
2.5 mL, and once the measurements were completed, the pH was immediately verified using an 
Accumet AR15 pH meter to ensure that the pH of the buffer did not change as a result of the 
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addition of protein. Each of the reported measurements in the near-UV / visible range represents 
the average of three accumulated spectra. 
CD spectra in the near-UV/visible range (500-260 nm) were collected in the presence or 
absence of ALA at pH 9.5 and 37 °C. The experiments were performed in 50 mM AMPSO 
buffer, pH 9.5, with ALAS and ALA concentrations of 1 mg/mL and 4 mM, respectively. In 
order to prevent changes in the buffer pH as a result of the high acidity of ALA, 4 mM ALA 
(from 0.5 M stock) was neutralized with equal volume of 1 M NaOH prior to initiating the 
reaction. The pH of the buffer, measured after adding 4 mM ALA to the enzyme, was 9.5. 
 
 Reaction with ANS 
Fluorescence spectra for the reaction between ANS and wild-type mALAS2 were 
collected using a Shimadzu RF 5301PC spectrofluorophotometer. All experiments were 
performed at either 20 or 37 ºC and the following pH values: 1, 2, 3, 7.5, 8.5, 9.5, and 10.5. 
Identical buffers were used as those described in the circular dichroism measurement section.  
Due to the low solubility of ANS in water, stock solution of 50 mM ANS was initially prepared 
in dimethyl sulfoxide (DMSO), which was further diluted in deionized water to prepare a stock 
of 4 mM ANS. Reactions at the pH value of interest were performed by incubating 1 µM wild-
type mALAS2 (0.06 mg/mL), 20 µM ANS, and 20 mM buffer for 1 hour at either 20 or 37 ºC.  
As negative controls, reactions at the pH value of interest were performed in the absence of 
protein by incubating 20 µM ANS and 20 mM buffer for 1 hour at either 20 or 37 ºC. 
Fluorescence spectra were then collected at either 20 or 37 ºC by monitoring the emission in the 
400-600 nm range, following excitation at 375 nm. A cell with a 0.3 cm path length was used 
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and the temperature in the cell holder was regulated using a circulating water bath. All reactions 
were performed in triplicates. 
   
 Acrylamide quenching of intrinsic protein fluorescence  
  The accessibility of tryptophans in wild-type mALAS2 was examined by monitoring the 
fluorescence spectra resulting from the quenching of the intrinsic fluorescence of the enzyme 
upon reaction with acrylamide. All reactions were conducted at either 20 or 37 ºC and the 
following pH values: 1, 7.5, and 9.5. The buffers used were: 20 mM KH2PO4, pH 1; 20 mM 
phosphate, pH 7.5 (16 mM K2HPO4 and 4 mM KH2PO4); 20 mM AMPSO, pH 9.5. Reactions at 
the pH value of interest were performed by incubating 1 µM wild-type mALAS2 (0.06 mg/mL), 
acrylamide, and 20 mM buffer for 5 minutes at either 20 or 37 ºC.  To ensure that the pH of the 
reaction was not modified by the addition of acrylamide, 2 M acrylamide stock solution was 
prepared in the following buffers: 20 mM KH2PO4,  pH 1.0; 20 mM phosphate, pH 7.5 (16 mM 
K2HPO4 and 4 mM KH2PO4); 20 mM AMPSO, pH 9.5. Fluorescence spectra were collected on a 
Shimadzu RF 5301PC spectrofluorophotometer by monitoring the emission at 340 nm upon 
excitation at 280 nm. During the collection of the spectra, the temperature in the cell holder was 
maintained at either 20 or 37ºC, and a cell with a path length of 0.3 cm was used. All reactions 
were performed in triplicates. The data resulting from the quenching of the intrinsic fluorescence 
were analyzed using the Stern-Volmer equation (Eq.4.1), 
                             ிబி ൌ 1 ൅ ܭ௦௩ሾQሿ                         Eq. 4.1                                     
where F0 is the fluorescence emission in the absence of acrylamide, F is the emission at a 
specific concentration of acrylamide, Ksv is the dynamic quenching constant, and Q is the 
concentration of acrylamide. 
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 Colorimetric assay for determination of ALAS activity 
  The catalytic activity of wild-type mALAS2 was examined using a colorimetric assay, 
which, briefly, involves the quantitation of the ALA-derived pyrrole upon reaction with Ehrlich’s 
reagent by monitoring the absorbance at 552 nm (23). All reactions were performed at 37 ºC in 
the acidic and alkaline pH ranges. Identical buffers were used as described in the circular 
dichroism measurement section, with the exception that the buffer concentration was 100 mM. 
Preliminary studies demonstrated that the addition of substrates did not modify the pH value of 
the reaction, with the exception at pH 10.5, where the addition of 50 mM glycine lowered the pH 
to 10.3 (data not shown). The reaction assay was performed in the following way: 4 µM of wild-
type mALAS2 (from a 220 µM mALAS2 stock ) was added to a reaction tube containing 100 
mM buffer at the pH of interest, and the sample was equilibrated at 37 ºC for 10 minutes prior to 
addition of substrates. Then to each reaction tube, 50 mM glycine (from a 2 M stock of glycine) 
and 100 µM succinyl-CoA (from an 8.3 mM stock of succinyl-CoA) were added, and the sample 
was immediately returned to the water bath. Incubation for 30 minutes at 37 ºC followed. The 
reactions were quenched by adding ½ reaction volume of 50 % TCA to each reaction tube.  
Following centrifugation at 12000 x g for 4 minutes at room temperature, aliquots were removed 
and placed in separate reaction tubes. Then, final concentration of 3.3 % acetylacetone / 0.3 M 
sodium acetate was added and incubation at 80 ºC for 10 minutes followed. The samples were 
cooled down to room temperature and equal volume of modified Ehrlich reagent (23) was added. 
After incubation for 15 minutes at room temperature, absorbance spectra in the 650-500 nm 
region were collected, and from the absorbance at 552 nm, the concentration of ALA was 
determined using extinction coefficient of 45 (mmol/L)-1·cm-1. For each reaction performed at a 
given pH a negative reaction control was included, where the reaction was quenched prior to the 
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addition of substrate by adding ½ reaction volume of 50 % TCA. The negative controls were 
subjected to the same colorimetric assay procedure.  
     To determine the steady-state kinetic parameters of mALAS2, the steady-state activity of 
mALAS2 was measured at 37 °C, at either pH 7.5 or 9.5, using the above described colorimetric 
assay with slight modifications. The assays were performed by varying the concentration of 
succinyl-CoA (0-400 µM) while keeping the concentration of glycine fixed at 200 mM. In 
preliminary studies, we established that the pH of the buffer did not change upon addition of 
substrates within the range of substrate concentrations used. At physiological pH, the initial 
velocities were determined by incubating the wild-type enzyme (4 µM) with both substrates for 1 
minute, and then quenching the reaction with ½ reaction volume of 50 % TCA and quantifying 
the formation of ALA. For reactions at pH 9.5, which were performed in 250 mM AMPSO 
buffer, the initial velocities were determined by incubating the enzyme (4 µM) with the 
substrates for a period of 20 minutes followed by quenching of the reaction with acid. The initial 
velocities, expressed as the concentration of ALA produced per minute, were plotted against the 
concentration of succinyl-CoA, and the data were fitted to the Michaelis-Menten equation (Eq. 
4.2) using non-linear regression analysis. Km and kcat values were determined from the fitted data. 
All data were analyzed using the program SigmaPlot. 
                                                                 ݒ ൌ ௏೘ೌೣሾௌሿ௄೘ାሾௌሿ                                                Eq. 4.2 
 
 Absorbance spectra of mALAS2 and free PLP at various pH values  
The absorbance spectra of wild-type mALAS2 and free PLP in several different buffers 
were recorded at 20 °C using a Shimadzu UV-2401 PC spectrophotometer. The buffers were: 50 
mM K2HPO4, pH 1.0, 50 mM K2HPO4, pH 2.0, 100 mM citrate, pH 3.0 (83 mM citrate 
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dihydrate, 17 mM sodium citrate dihydrate), and 50 mM phosphate, pH 7.5 (40 mM K2HPO4, 10 
mM KH2PO4). Spectra were collected immediately upon diluting ALAS in the respective buffer 
at intervals of 5 minutes for a time period of 20 minutes. The protein concentration was 40 µM, 
while that of free PLP was 50 and 200 µM at physiological and acidic pH, respectively. 
 
 Dynamic light scattering 
 Dynamic light scattering measurements were conducted on a Wyatt DynaPro plate reader 
at 25 °C. Wild-type mALAS2 was diluted to a final concentration of 1 mg/ml in the following 
buffers: 50 mM K2HPO4, pH 1.0, 50 mM K2HPO4, pH 2.0, 100 mM citrate, pH 3.0, 50 mM 
K2HPO4, pH 7.5 and 50 mM AMPSO, pH 9.5. The protein samples and all buffers were filtered 
through 0.22 µm filters prior to measurements. 
 
 Results 
  Effects of pH and temperature on the secondary structure of mALAS2 
  CD spectra in the far-UV region (195-260 nm) were collected to examine how variations 
in temperature and pH affect the secondary structure of wild-type mALAS2. At physiological 
pH, the far-UV CD spectrum of mALAS2 resembles that of proteins with ordered secondary 
structure, and changing the temperature from 20 to 37 ºC has no effect on the secondary structure 
(Fig. 4.2). As the pH is lowered to a value of 2.0, the protein becomes progressively disordered; 
under these conditions, and in comparison to physiological pH, the 208 nm elliptical minimum is 
blue-shifted to 204 nm and the intensity of the 222 nm minimum is decreased (Fig. 4.2A and B). 
This trend, however, does not continue with further decreases in pH. In fact, the far-UV CD 
spectrum of mALAS2 at pH 1.0 is similar to the spectrum collected at pH 7.5, indicating that the 
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secondary structure is restored to near-native levels (Fig. 4.2A and B). Since hydrochloric acid 
was used to adjust the pH of the phosphate buffer, and it is present at higher concentrations at pH 
1.0 than at pH 2.0, the acid-induced refolding observed in the buffer at pH 1.0 is attributed to the 
ability of negative chloride ions to minimize repulsion among positively charged groups of 
mALAS2 (see discussion). The integrity of the secondary structure is not significantly modified 
by changes in pH in the alkaline range, with only modest effects detected at pH 10.5 (Fig. 4.2C 
and D). All far-UV CD spectra were similar at 20 and 37 ºC, indicating that moderate increase in 
temperature does not disrupt the secondary structure. 
 
 Effects of pH and temperature on the tertiary structure of mALAS2 
The effects of pH and temperature on the tertiary structure of mALAS2 were 
characterized from the spectra in the near-UV CD region (310-260 nm). As the pH varies from 
physiological to alkaline conditions, the rigidity of the tertiary structure is disrupted, as discerned 
from the decreased ellipticity in the near-UV signal (Fig. 4.3A and B). The effect is amplified 
when the temperature increases from 20 to 37 °C, implying that temperature and alkalinity 
enhance conformational mobility and modification in ionic interactions, which significantly 
disrupt the tertiary structure of mALAS2 (Fig. 4.3A-D). This can be clearly seen at pH 9.5 upon 
increasing the temperature to 37 °C (Fig. 4.3D). 
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Figure 4.2. Effects of pH and temperature on the secondary structure of mALAS2. Far-UV CD 
spectra collected at (A) acidic pH and 20 °C, (B) acidic pH and 37 °C, (C) alkaline pH and 20 °C, (D) 
alkaline pH and 37 °C. The colors of the spectra are: pH 1 (pink), pH 2 (purple), pH 3 (gray), pH 7.5 
(black), pH 8.5 (red), pH 9.5 (blue), and pH 10.5 (cyan). 
 
  Moreover, under alkaline conditions, the actual decrease in the intensity of the near-UV 
CD signal is far more pronounced than what it seems in Fig. 4.3. This is because in comparison 
to physiological pH, the 330 nm maximum that results from the internal aldimine of ALAS is 
profoundly modified in alkaline solution (Fig. 4.4) and thus making the ellipticity at 305 nm 
much more intense than that at pH 7.5 (Figs. 4.3 and 4.4). To account for this disparity and 
present the actual reduction in elliptical signal more clearly, we have normalized the data by 
subtracting the 280 nm ellipticity from that at 305 nm; the normalized data are presented in Fig. 
4.5.  In the acidic pH range, the CD signal in the near-UV region is at baseline close to zero, 
indicating that the enzyme has no rigid tertiary structure (Fig. 4.3). Importantly, the near and far-
UV CD data indicate that under specific acidic (pH 1 and pH 3) and alkaline (pH 9.5/37 °C and 
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pH 10.5) conditions, mALAS2 exists in a molten globule state, where it retains native levels of 
secondary structure, without having rigid tertiary structure. At pH 2.0, the enzyme is noticeably 
unfolded as it follows from the specific changes in the far-UV CD spectrum. 
 
 
 
Figure 4.3. Effects of pH and temperature on the tertiary structure of mALAS2. Near-UV CD 
spectra collected at different acidic and alkaline pH values at (A) 20 °C, and (B) 37 °C. (C) Spectra at 20 
°C (solid) and 37 °C (dashed) at pH 7.5. (D) Spectra at 20 °C (solid) and 37 °C (dashed) at pH 9.5. The 
colors of the spectra are: pH 1 (pink), pH 2 (purple), pH 3 (gray), pH 7.5 (black), pH 8.5 (red), pH 9.5 
(blue), and pH 10.5 (cyan). 
 
 
99 
 
 
Figure 4.4. CD spectra of mALAS2 in the 260-350 nm range at (A) 20 °C and (B) 37 °C. The colors 
correspond to: pH 7.5 (black), pH 8.5 (red), and pH 9.5 (blue). 
 
 
Figure 4.5 Dependence of CD ellipticity difference (Δθ280-305) with pH. The CD ellipticity difference 
(Δθ280-305) was calculated by subtracting the degree of ellipticity at 280 nm from that at 305 nm. The 
symbols correspond to the spectra collected at different temperatures: 20 °C (squares) and 37 °C 
(triangles). 
 
 Effects of pH and temperature on the PLP-binding site of mALAS2 
   PLP-dependent enzymes usually display a positive dichroic signal in the 500-310 nm 
region of the CD spectrum as a result of the positioning of the internal aldimine in a chiral, active 
site environment [(11) and references therein]. At physiological pH value of 7.5, the CD 
spectrum of mALAS2 in the 500-310 nm region displays two positive dichroic bands with 
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maxima at 430 and 325 nm, where the intensity of the former is more pronounced (Fig. 4.6). 
However, as the alkalinity of the solution increases, the chiral environment of the internal 
aldimine changes (Fig. 4.6A and B). Starting at pH 8.5, the 325 nm dichroic band becomes more 
pronounced than the 430 nm band. This trend continues with further increases in pH and is 
accompanied by a shift of the 325 nm maximum toward shorter wavelengths, such that at pH 9.5 
the maximum is shifted to 317 nm and to 312 nm at pH 10.5 (Fig. 4.6A and B). In the acidic pH 
range (pH 1-3), the CD signal that results from the internal aldimine of mALAS2 is lost, 
suggesting severe disruption of the active site environment or dissociation of PLP from the 
enzyme (Fig. 4.6C and D). With the exception of the spectra collected at pH 10.5, the spectra 
collected at all other pH values were nearly identical at either 20 or 37 ºC (Fig. 4.6). 
 
Figure 4.6. Effects of pH and temperature on the chiral active site environment of the mALAS2 
internal aldimine. CD spectra in the 500-310 nm region collected at (A) alkaline pH and 20 °C, (B) 
alkaline pH and 37 °C, (C) acidic pH and 20 °C, (D) acidic pH and 37 °C. The colors of the spectra 
correspond to: pH 1 (pink), pH 2 (purple), pH 3 (gray), pH 7.5 (black), pH 8.5 (red), pH 9.5 (blue), and 
pH 10.5 (cyan) 
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  In order to examine whether PLP remains covalently bound to the active site of ALAS at 
acidic pH, the absorbance spectra of mALAS2 were recorded and compared to that of free PLP 
(Fig. 4.7). At physiological pH, the absorbance spectrum of free PLP displays a maximum at 390 
nm, which differs from the spectrum of ALAS, where, as a result of the Schiff base linkage 
between PLP and K313, the maximum is red shifted to 415 nm (Fig. 4.7A). In contrast, PLP does 
not bind covalently to the active site lysine of ALAS under acidic conditions. In fact, at acidic 
pH, a time-dependent dissociation of PLP from the active site of ALAS was observed. The 
spectra of ALAS collected at time point zero and at pH values 1.0-3.0 resembled that of ALAS at 
physiological pH; however, within the time period of 20 minutes, the spectra of holo-ALAS 
under acidic conditions became similar to the spectra of free PLP in acidic solution, implying 
that the cofactor dissociated from the active site (Fig. 4.7B-D). No significant changes in the 
spectra of holo-ALAS were observed at physiological pH within the time period used in this 
study, indicating that PLP remained covalently bound to the enzyme (Fig. 4.7A). Further, the 
spectra of free PLP did not change within the experimental time period and at all examined pH 
values (data not shown). 
 
 Reaction with ANS  
  ANS is a fluorescence probe that is commonly used to characterize the exposure of 
hydrophobic surfaces in proteins in order to monitor the formation of partially folded molten 
globule-like intermediates (24). Upon reaction with hydrophobic clusters, the emission intensity 
of ANS intensifies and is shifted toward shorter wavelengths (24). The fluorescence spectra for 
the reaction between mALAS2 and ANS are shown in Fig. 4.8, while graphical representation of 
the wavelength of emission maxima and emission intensity are shown in Fig. 4.9A and B, 
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respectively. In the absence of protein, ANS in the pH range between 7.5-10.5 displays emission 
maxima at 534 nm of equal intensity, which are not affected when the temperature changes from 
 
 
Figure 4.7. Absorbance spectra of mALAS2 and free PLP recorded at various time intervals and 
pH values. (A) pH 7.5: ALAS at time intervals of 0 min (purple), 5 min (cyan), 10 min (blue), 15 min 
(pink), 20 min (red), and free PLP (orange). (B) pH 3.0, (C) pH 2.0, and (D) pH 1.0. The color code for 
the spectra of ALAS at the different time intervals and free PLP in panels (B)-(D) is the same as in panel 
(A). For comparison, the spectrum of ALAS collected at pH 7.5 (black) is also shown in panels (B)-(D). 
Note that while the spectra of ALAS in acidic pH at 0 min (purple) resembles that of ALAS at pH 7.5 
(black) [panels (B)-(D)], with time, at acidic pH, PLP dissociates from ALAS, with the spectra of ALAS 
collected at 20 min (red) resembling that of free PLP (orange) [panels (B)-(D)]. No time-dependent 
changes were detected in the spectra of free PLP at any pH value (data not shown). 
 
20 to 37 ºC. However, upon reacting with mALAS2, the fluorescence emission of ANS 
intensifies and the maximum is shifted toward shorter wavelengths (Fig. 4.9). The reactivity 
between ANS and mALAS2 increases as the alkalinity and temperature are increased, implying 
that the hydrophobic clusters of mALAS2 become more exposed to the solvent as a result of 
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disruption in the rigidity of the tertiary structure (Figs. 4.8 and 4.9). In the acidic pH range (pH 
1-3), when ANS reacts with mALAS2, the shift in the emission maximum toward shorter 
wavelengths is comparable to that observed under alkaline conditions; however, the emission 
intensity of ANS is significantly more pronounced (Figs. 4.8 and 4.9). This finding indicates 
potential differences in the exposure of hydrophobic clusters in acidic and alkaline solution or 
presence of some internal quenchers at alkaline pH. 
 
Figure 4.8.  Fluorescence spectra for the reaction between ANS and mALAS2. (A) Spectra in pH 
range 1-3, and (B) pH range 7.5-10.5. Solid lines represent spectra collected at 20 °C, and dashed lines at 
37 °C. The colors are: ANS-mALAS2 complex at pH 1 (pink), pH 2 (purple), pH 3 (grey), pH 7.5 (black), 
pH 8.5 (red), pH 9.5 (blue), pH 10.5 (cyan); free ANS is shown in orange. 
 
Figure 4.9. Reaction between ANS and mALAS2 at different pH values at 20 or 37 °C. (A) 
Wavelength of emission maxima. (B) Fluorescence emission intensity. The colors correspond to: free 
ANS at 20 °C (black), free ANS at 37 °C (gray), ANS in the presence of mALAS2 at 20 °C (blue), and 
ANS in the presence of mALAS2 at 37 °C (pink). 
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 Acrylamide quenching of intrinsic protein fluorescence 
  Acrylamide quenching studies were performed to characterize how changes in pH and 
temperature affect the orientation of tryptophans in mALAS2. The data fitted to the Stern-
Volmer equation are presented in Fig. 4.10, whereas the calculated dynamic quenching constants 
are in Table 4.1. At physiological pH, as the temperature changes from 20 to 37 ºC, the dynamic 
quenching constant, Ksv, decreases from 8 to 5.1 M-1. This could imply that as the temperature 
increases, the protein becomes more dynamic, causing the repositioning of some tryptophans in 
an environment that is less accessible to the quencher. In contrast, at pH 1.0 and pH 9.5, as the 
temperature increases to 37 ºC, the Ksv values remain identical to those observed at 20 ºC. 
However, the Ksv values obtained at pH 1.0 and pH 9.5 are different, indicating subtle differences 
in the accessibility of tryptophans under acidic and alkaline conditions. 
 
Figure 4.10. Acrylamide quenching of intrinsic fluorescence of mALAS2. (A) pH 1.0 and 20 °C, (B) 
pH 7.5 and 20 °C, (C) pH 9.5 and 20 °C, (D) pH 1 and 37 °C, (E) pH 7.5 and 37 °C, (F) pH 9.5 and 37 
°C. 
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Table 4.1 
Dynamic quenching constants at different pH and 
temperature values 
pH Ksv at 20 ºC
M-1
Ksv at 37 ºC
M-1
1.0 7.2 ± 0.1 6.7 ± 0.3
7.5 7.9 ± 0.2 5.1 ± 0.2
9.5 5.6 ± 0.1 5.7 ± 0.3
 
 Dynamic light scattering 
  Dynamic light scattering was used to examine the propensity of ALAS to self-associate 
into higher oligomeric species at different pH values. The greatest propensity for self-association 
into higher oligomers was observed at pH 3.0, although a significant heterogeneous oligomeric 
population was observed at pH 2.0, and to a lesser extent at pH 1.0, where the hydrodynamic 
radius of the most populous species is over 2-fold greater than at physiological pH (Fig. 4.11). 
Since in the pH range 6.5-3.2, mALAS2 precipitates out of solution, forming visibly insoluble 
aggregates (data not shown), the extent of protein association into higher oligomers depends on 
the proximity of the buffer pH to the lower limit of solubility (~pH 3.1). There was no significant 
protein association at either pH 7.5 or 9.5 (Fig. 4.11), indicating that at these pH values, 
mALAS2 is predominantly a dimer. Interestingly, even at 25 °C, the hydrodynamic radius at pH 
9.5 is increased by 12 % when compared to that at pH 7.5. This observation is in agreement with 
the CD and ANS data, which showed that structural perturbations are associated with increased 
alkalinity. 
   
 Is catalysis possible under conditions in which ALAS, devoid of ligands, lacks a rigid 
tertiary structure?  
  To assess if the enzyme retains catalytic activity under conditions in which its structural 
integrity is compromised, a colorimetric assay was used to determine the mALAS2-catalyzed 
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formation of ALA at different acidic and alkaline pH values. No activity was detected in the 
acidic range, while the enzyme remains active in the alkaline pH range up to pH 9.5 (Table 4.2). 
This indicates that, although the reaction velocity is about 10-fold lower than at physiological 
pH, mALAS2 is active at 9.5 and 37 °C, conditions under which the enzyme adopts, in the 
absence of substrates, the molten globule state. 
 
Figure 4.11. Size distribution of mALAS2 at pH values of (A) pH 9.5, (B) pH 7.5, (C) pH 3.0, (D) pH 
2.0, and (E) pH 1.0. All experiments were performed using 1 mg/ml protein and at 25 °C. 
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Table 4.2 
Velocities for the mALAS2-catalyzed formation of 
ALA at different pH values
pH V
(nmol·mg-1·min-1)
10.3 N.A.a
 9.5 0.14
 8.5 1.10
7.5 1.10
3.0 N.A.a
2.0 N.A.a
1.0 N.A.a
aN.A., no measurable activity 
 
 
Comparison of the steady-state kinetic parameters of the alkaline molten globule, as 
described for the ALAS state at pH 9.5/37 °C, with those of natively folded ALAS (pH 7.5/37 
°C) indicated a 40-fold decrease and a 6-fold increase in the kcat and  ܭ୫ୗେ୭୅ values, respectively 
(Table 4.3). However, the most drastic reduction was in the specificity constant for succinyl-
CoA, ݇ୡୟ୲ ܭ୫ୗେ୭୅⁄ ,	 which was 250-fold lower at pH 9.5 than at pH 7.5 (Table 4.3). The ܭ୫ୋ୪୷ and  
݇ୡୟ୲ ܭ୫ୋ୪୷⁄  values could not be determined accurately at alkaline conditions because the pH 
changed at concentrations of glycine greater than 200 mM. 
 
 
Table 4.3 
Steady-state kinetic parameters of mALAS2 determined at 37 °C and 
pH 7.5 or pH 9.5 
pH ݇ୡୟ୲ 
(min-1) 
 ܭ୫ୗେ୭୅ 
(µM) 
 ݇ୡୟ୲ ܭ୫ୗେ୭୅⁄  
(min-1.µM-1) 
7.5 2.80 ± 0.10 16 ± 4 175 x 10-3 ± 50 x 10-3  
9.5 0.07 ± 0.01 103 ± 32 0.68 x 10-3 ± 0.2 x 10-3 
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 Is ligand binding to ALAS coupled to its folding in the alkaline molten globule?  
   To assess whether ligand binding stabilizes the tertiary structure of ALAS, CD spectra in 
the near-UV range were collected, at pH 9.5 and 37 °C, in the presence and absence of ALA 
(Fig. 4.12). The binding of ALA to the alkaline molten globule state of ALAS increases the 
elliptical signal in the near-UV range, implying that ALA binding to ALAS induces folding by 
reducing structural fluctuations. A similar substrate-induced stabilization of the tertiary structure 
is probably necessary for catalysis. Of relevance, the observed increase in ellipticity results from 
stabilization of the tertiary structure, rather than from unbound ALA, since the elliptical signal of 
ALA in the absence of enzyme in the near-UV region is near baseline (data not shown). Further, 
it was not possible to perform the experiments in the presence of substrates, because succinyl-
CoA has an absorbance maximum at ~260 nm, and at concentrations greater than 100 µM (i.e., 
concentration greater than the Km value at pH 9.5) interferes with the acquisition of the CD data. 
 
 
Figure 4.12. Binding of ALA to the alkaline molten globule state of ALAS restricts fluctuations in 
the tertiary structure. Near-UV CD spectra were collected at 37 °C with the reactants in 50 mM 
AMPSO, pH 9.5. Dashed and solid lines correspond to mALAS2 in the absence and presence of ALA, 
respectively. 
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 Discussion 
The integrity of the secondary structure of mALAS2 is rather resilient to changes in pH 
in the alkaline range. In contrast, the secondary structure becomes disrupted at pH 2.0 where the 
enzyme exists as a stable, partially folded intermediate. Since at pH 2.0, mALAS2 is positively 
charged due to protonation of its aspartates and glutamates side groups, we hypothesize that the 
partial unfolding of the secondary structure results from increased repulsion amongst the 
positively charged groups. One would therefore expect greater disruption as the pH is further 
decreased; however, rather than becoming less structured, the secondary structure of mALAS2 at 
pH 1.0 is restored to nearly native levels (Fig.4.2).  
      ALAS is by no means the only protein whose secondary structure content becomes 
restored under extreme acidic conditions. In fact, Goto et al. were the first to describe the 
phenomenon of acid-induced refolding for three different proteins: cytochrome c, apomyoglobin, 
and β-lactamase (25). The authors showed that the aforementioned proteins, which exist in fully 
unfolded forms at pH 2.0, restore their secondary structure content to nearly native levels as the 
pH is further decreased by increasing the concentration of hydrochloric acid (25). The refolding 
resulted from the ability of negatively charged chloride ions to minimize repulsion among the 
positively charged groups of the protein (25, 26). We also propose that the refolding of the 
secondary structure of mALAS2 at extremely low pH results from the ability of the increased 
concentration of chloride ions (which are present in the buffer since the pH was adjusted with 
hydrochloric acid) to minimize repulsion among positively charged groups. This phenomenon of 
acid-induced (25, 26) or anion-induced (27) refolding of acid-unfolded state was also described 
earlier for several proteins, such as β-lactamase (28), apomyoglobin (29), cytochrome c (30, 31), 
various heme proteins (32), Staphylococcal nuclease (27, 33), ribulosebisphosphate carboxylase 
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(Rubisco) from Rhodospirillum rubrum (34), human serum albumin (35), α-chymotrypsinogen 
(36), rabbit muscle pyruvate kinase (37), jack bean urease (38), and many other proteins (39, 40). 
      Under specific acidic (pH 1.0 and pH 3.0) and alkaline (pH 9.5 / 37 °C and pH 10.5) 
conditions, mALAS2 exists in a molten globule state, where its secondary structure is mainly 
preserved, while the rigidity of the tertiary structure is lost. This finding implies an important 
role for ionic interactions in stabilizing the tertiary structure, because upon increasing the same 
type of electric charges (either positive or negative), tertiary contacts are disrupted. Ultimately, 
this disruption leads to loosening of the side chain packing in the protein core and conversion of 
mALAS2 into a molten globule state. Interestingly, the acidic and alkaline molten globule states 
of mALAS2 are assumed independently of temperature, with the exception that at pH 9.5 the 
molten globule state is observed only at 37 °C. Greater structural mobility, which ensues from 
increases in temperature, is probably necessary for the conversion of mALAS2 into the molten 
globule state at pH 9.5. 
ANS-mALAS2 binding experiments further corroborate that the enzyme populates the 
molten globule state under the aforementioned conditions, as inferred from the observation that 
the reactivity of the enzyme with ANS is more pronounced in the alkaline molten globule state 
than in the native state (pH 7.5). These findings strongly imply greater exposure of the 
hydrophobic clusters of mALAS2 in the alkaline solvent due to disruption of the tertiary 
structure. 
Interestingly, in the acidic pH range, the fluorescence emission intensity of ANS upon 
reacting with mALAS2 is significantly more prominent than that observed in the alkaline pH 
range (Fig. 4.9). Since at acidic pH there is a greater propensity for self-association, due to the 
presence of partially folded intermediates, and thus heterogeneity in ALAS oligomeric species, 
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we propose that the increase in fluorescence emission intensity observed at acidic pH results 
from ANS interaction with the hydrophobic surfaces of partially folded intermediates and with 
those of higher oligomeric species. The fluorescence emission intensity of ANS has been 
reported to increase upon interaction with self-associating proteins forming higher oligomers 
(41-43). 
Quenching of the protein intrinsic fluorescence with acrylamide indicates that the 
tryptophans of mALAS2 at pH 1.0 and pH 9.5 have different accessibility to the quencher, as 
inferred from their respective Ksv values. This finding implies that the acidic and alkaline molten 
globule states of mALAS2 differ subtly, as also suggested by the ANS experiments. At 
physiological pH, changing the temperature from 20 to 37 ºC proceeds with a decrease in the 
dynamic quenching constant. We hypothesize that an increase in temperature results in greater 
mobility of the conformational ensemble of mALAS2, which in turn reduces the accessibility of 
tryptophans to the quencher.  
  In the acidic pH range, the CD signal resulting from the positioning of the internal 
aldimine within the chiral active site environment of mALAS2 is lost (Fig. 4.6). The 
disappearance of the CD signal results from the dissociation of PLP from the active site, and this 
process, as validated by absorbance spectroscopy, occurs in a time-dependent manner (Fig. 4.7). 
Our results are in good agreement with those of NMR studies of the reaction between PLP and 
free lysine, which led Chan-Huot et al. to conclude that, at pH values below 4, PLP no longer 
forms a Schiff base with lysine, but rather exists as a free hydrate (44). Moreover, time-
dependent dissociation of PLP has been reported for the guanidine deuterochloride denaturation 
of aspartate aminotransferase (45).  
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Increasing alkalinity causes the 330 nm dichroic band to intensify and the 420 nm band to 
weaken. These findings indicate that at pH values of 8.5 or higher, the orientation of the internal 
aldimine is different from that observed under physiological conditions, at which the 
corresponding 420 nm band predominates. Importantly, the chiral environment of the internal 
aldimine is modified in favor of the species with the 330 nm dichroic band at approximately the 
same pH value at which mALAS2 becomes less structured. If the alteration in the chirality of the 
internal aldimine stems from ionization of group(s) important for the positioning of the cofactor 
or through water molecules that modify previously established interactions between PLP and 
active site groups, then a shift to a less structured conformational subset probably assists the 
tautomeric interconversion by making the active site more accessible to the solvent. However, 
we cannot exclude the possibility that the alteration in the chiral environment of the internal 
aldimine results solely from conformational rearrangements. It is interesting to note that upon 
stabilization of a particular conformational subset, shift in the tautomeric equilibrium of the 
internal aldimine toward the 340 nm absorbance species was reported for tyrosine phenol lyase, 
when this fold type I PLP-dependent enzyme was encapsulated in wet nanoporous silica gel (46). 
While the enzyme does not retain any measurable activity in the acidic pH range under 
the assay conditions, it remains active in the alkaline pH range up to pH 9.5. The most surprising 
finding is that mALAS2 is catalytically active even in the molten globule state (pH 9.5 and 37 
ºC), with the holoenzyme as a highly dynamic ensemble of interconverting conformations. 
However, the catalytic activity of mALAS2 at pH 9.5 and 37 ºC is severely compromised, with 
40- and 250-fold reductions in the kcat and ݇ୡୟ୲ ܭ୫ୗେ୭୅⁄ 	 values, respectively, in relation to those 
determined at physiological pH (Table 4.3), implying that the ability of the enzyme to effectively 
convert its substrates into products is impaired. Clearly, ligand binding to ALAS partly restricts 
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the conformational fluctuations observed in the alkaline molten globule state of the holoenzyme 
(Fig. 4.12). The ligand-induced conformational stabilization is likely to determine the structural 
reorganization and transition to a conformation amenable for catalysis. However, even with the 
ligand-dependent conformational stabilization, the catalytic activity of ALAS remains hindered, 
suggesting an energetic penalty associated with the structural reorganization to the catalytically 
competent conformation that contributes, at least partly, in lowering the catalytic efficiency of 
the enzyme. Since no activity was detected in the acidic pH range and at pH 10.5, where ALAS 
also assumes a molten globule state, the abolished activity may not entirely stem from structural 
disorder, but rather at acidic pH, it results from dissociation of PLP from the active site, and at 
pH 10.5, from deprotonation of the catalytically important Lys313, which acts as a base and acid 
catalyst during the reaction cycle (47). 
In this study we have shown that ALAS exists as an intrinsically disordered molten 
globule under specific acidic and alkaline conditions. Yet the question remains whether under 
physiologically relevant conditions, apart during the folding process, ALAS ever exists in an 
intrinsically disordered state. One way to address this question is to examine if any of the XLSA 
mutations affect the folding pathway of ALAS, where the variant fails to fold to the native state, 
and populates a less structured state. Of particular interest are XLSA mutations in patients 
responsive to pyridoxine treatment (4). About two-thirds of XLSA patients respond to treatment 
with pyridoxine (which, like PLP, is a B6 vitamer). While the mechanism through which 
pyridoxine restores the catalytic activity of ALAS is not understood (4), the presumption has 
been that the mutated enzymes bind PLP less tightly, and given that pyridoxine is enzymatically 
converted to PLP, the increased PLP concentration would lead to increased ALAS activity. Since 
the binding of ligands has been shown to promote structural disorder-to-order transition in 
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certain proteins (48), it would be useful to examine if there are any XLSA mutations where the 
binding of PLP to the ALAS variants promotes conversion of the enzyme to a more structured 
and catalytically competent conformation. 
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Chapter Five 
 
Summary and conclusion 
 
 
 
Ever since the purification of ALAS and identification that PLP is utilized as a cofactor, 
the central question pertinent to the reaction mechanism was weather the external aldimine 
formed between glycine and PLP would be deprotonated or decarboxylated to generate a 
carbanion intermediate that can condense with succinyl-CoA (1). Radiolabeling, mutagenic, and 
kinetic studies provided evidence in favor of initial deprotonation of the glycine external 
aldimine, implying that the subsequent 2-amino-3-ketoadipate intermediate is on the reaction 
pathway, and that ALA is generated upon decarboxylation of this intermediate (2-7). However, 
direct experimental evidence for the inferred 2-amino-3-ketoadipate intermediate was lacking, 
mainly because of the challenges in isolating this intermediate with its carboxyl group intact, 
given the rapidity of the enzymatically catalyzed reaction (6). To surmount the challenges 
presented by the chemical liability of the 2-amino-3-ketoadipate intermediate, we resorted to 
using the pseudo substrate, O-methylglycine, and examined the ALAS-catalyzed reaction. Since 
the carboxyl group of O-methylglycine is methylated and protected against decarboxylation, 
condensation with succinyl-CoA is only possible through initial deprotonation of the C-α. Using 
LC-MS/MS to study the ALAS reaction with O-methylglycine and succinyl-CoA we confirmed 
the presence of the methyl ester of the 2-amino-3-ketoacid intermediate, implicating its existence 
on the reaction pathway. Consistent with previous reports (2, 3, 6, 7), our results are supportive 
of an ALAS-catalyzed reaction that entails initial proton removal from the glycine external 
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aldimine. This is further supported by the spectroscopic detection of the quinonoid intermediate 
upon reaction of glycine with mALAS2, which interconverts with the external aldimine at a 
similar rate, although we have estimated that in the absence of succinyl-CoA, the quinonoid 
intermediate is catalyzed by only a small fraction of the enzyme population.  
Interestingly, while ALAS is capable of utilizing acyl-CoA substrates other than 
succinyl-CoA (8), the enzyme shows strict specificity toward glycine as the only naturally 
occurring amino acid substrate (3, 9). In an effort to examine the kinetic basis of this specificity, 
we have conducted transient kinetic analyses, and observed that the progress curve of the 
reaction between mALAS2 and L-serine is characterized by a lag phase, not detectable during 
the reaction with glycine. The presence of a lag phase is commonly observed in hysteretic 
enzymes (10), implying that the entry of serine into the tightly packed active site of ALAS 
results in a conformational strain. Modeling of the L-serine external aldimine from the closely 
related Sphingomonas paucimobilis SPT into the active site of ALAS revealed differences 
between the orientations of serine and glycine. In fact, the model implied that the carboxyl group 
of L-serine prevents the productive binding of succinyl-CoA due to steric clashes. This 
unfavorable orientation of L-serine can in part explain the inability of ALAS to catalyze the 
condensation between L-serine and succinyl-CoA, with the reaction proceeding as far as the 
formation of the L-serine external aldimine. Moreover, the model predicted potential clashes 
between L-serine and T148. When we mutated this amino acid to an alanine, there was no lag 
phase in the progress curve for the reaction of the T148A variant and L-serine, consistent with 
the role of this threonine in modulating the enzymatic specificity toward the amino acid substrate 
(7, 9). Finally, a lag phase was also detected during the ALAS-catalyzed formation of the 
external aldimine with ALA, but not the quinonoid intermediate.  
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We have recently identified an alternative channel that serves as a potential path of entry 
and exit of glycine and ALA to and from the active site of Rhodobacter capsulatus ALAS (11). 
The opening and closing of this channel is partly regulated by N85’ from the glycine-rich stretch 
of the opposite monomer. Moreover, this asparagine also coordinates the positioning of succinyl-
CoA and the condensation intermediate in the active site, implicating important role for effective 
catalysis (12). In order to assess its effects on catalysis, we mutated the analogous asparagine of 
mALAS2 to a histidine (N150H), and performed detailed kinetic and equilibrium studies. 
Comparisons of the steady-state kinetic parameters with the wild-type enzyme revealed 50 % 
decrease in the kcat value of N150H, but without changes in ܭ୫ୗେ୭୅. Moreover, the binding 
affinity toward succinyl-CoA is not perturbed by the N150H mutation, since the Kd value of the 
variant is identical with that of wild-type mALAS2. Our data also revealed that the binding of 
succinyl-CoA to ALAS is primarily facilitated by the CoA rather than the succinyl-moiety, as 
evident from the identical Kd values that were obtained for succinyl-CoA and CoA. Interestingly, 
there is a notable difference between the Km and Kd values for succinyl-CoA. For the wild-type 
enzyme, the Kd value is about 230-fold greater than the Km value. These findings imply that 
ܭ୫ୗେ୭୅	does not represent a measure of substrate affinity analogous to the k-1/k1 term which 
describes the Kd, but rather it represents a complex kinetic function of all the rate constants in the 
pathway. 
When the N150H-catalyzed reaction with glycine and succinyl-CoA was examined 
during a single turnover using stopped-flow spectroscopy, we detected significant reductions in 
the observed pre-steady-state rates for the formation (k1) and decay (k2) of the quinonoid 
intermediate II, suggesting that N150 is important for effective catalysis of this intermediate, 
possibly by promoting attainment of a catalytically optimal orientation between the condensation 
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intermediate and reactive centers. Moreover, when the formation of the quinonoid intermediate 
for the N150H catalyzed reaction between glycine and succinyl-CoA was examined during 
multiple turnovers, prolonged decay of the quinonoid intermediate into the steady state was 
observed, in contrast to the steep decay of this intermediate for the wild-type reaction. This 
prolonged decay resulted from accelerated transformation of the product, ALA, into the 
quinonoid intermediate during the reverse N150H-reaction, catalyzed at a rate that is increased 
by 59 % than the wild-type reaction. Importantly, our results imply that N150 is essential in 
establishing catalytic balance between the forward and reverse reactions of mALAS2 by favoring 
formation of ALA over its non-productive transformation into the quinonoid intermediate. We 
arrived to this conclusion based on the differences that were detected in the rates of quinonoid 
intermediate formation during the forward (i.e., with glycine and succinyl-CoA) and reverse (i.e., 
with ALA) reactions catalyzed by the N150H and wild-type enzymes. In fact, relative to their 
respective forward reaction rates of quinonoid catalysis, N150H transforms ALA into the 
quinonoid intermediate at a rate that is 1.7-fold higher, while for wild-type ALAS, this reverse 
reaction with ALA is 6.3-fold lower. 
Since even subtle disturbances in the rate of ALA synthesis due to loss-of-function or 
gain-of-function mutations in the ALAS2 gene result in X-linked sideroblastic anemia (13) and 
X-linked dominant protoporphyria (14), respectively, it is evident that the necessity to evolve 
away from hypoactivity and hyperactivity must have been a defining evolutionary pressure in 
shaping the active site architecture of ALAS. Our results suggest that the active site environment 
of ALAS has also been optimized by evolution to minimize non-productive transformation of 
ALA and to establish a catalytic balance between the forward and reverse reactions. This 
catalytic balance was at least partly accomplished by the selection of the invariant N150, which 
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endowed ALAS with improved catalytic specificity toward the reaction with glycine and 
succinyl-CoA, and therefore, ensured that ALA is predominantly utilized for heme biosynthesis. 
Contrary to the assumption that catalysis is incompatible with structural disorder, certain 
enzymes have been shown to retain catalytic activity even when, devoid of ligands, they populate 
an intrinsically disordered molten globule state (15-18). In the molten globule state, proteins 
preserve native-like secondary structure content, but due to absence in the close packing of their 
side chains, the rigidity of the tertiary structure is disrupted (19). In this study, we have examined 
the effects of pH (1-3 and 7.5-10.5) and temperature (20 and 37 ºC) on the structural integrity of 
mALAS2 with the aim of characterizing whether catalysis is compatible with structural disorder. 
The secondary structure, as deduced from far-UV CD, was mostly resilient to pH and 
temperature changes. Partial unfolding was observed at pH 2.0, but further decreasing pH 
resulted in acid-induced refolding of the secondary structure to nearly native levels. This acid-
induced refolding resulted from minimization of the repulsion among positively charged groups 
due to association with negative chloride ions. The tertiary structure rigidity, monitored by near-
UV CD, was lost under acidic and specific alkaline conditions (pH 10.5 and pH 9.5/37 °C), 
where ALAS populates the molten globule state. As the enzyme became less structured with 
increased alkalinity, the chiral environment of the internal aldimine was also modified, with a 
shift from a 420 nm to 330 nm dichroic band. Under acidic conditions, the PLP cofactor 
dissociated from ALAS in a time-dependent manner as confirmed by absorbance spectroscopy. 
Reaction with 8-anilino-1-naphtalenesulfonic acid corroborated increased exposure of 
hydrophobic clusters in the alkaline and acidic molten globules, although the reaction was more 
pronounced with the latter, probably due to greater propensity for self-association into higher 
oligomers. Importantly, we have shown that the alkaline molten globule state (pH 9.5/37 °C) is 
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catalytically active, although the catalytic activity is severely compromised, with 40-fold and 
250-fold reductions of kcat and kcat/ܭ୫ୗେ୭୅, respectively, in comparison to those determined at 
physiological values. The binding of ALA to the alkaline molten globule state minimized 
conformational fluctuations, which is probably necessary for the enzyme to assume a 
catalytically competent conformation. Therefore, through effective coupling between the binding 
of ligands and folding, ALAS retains catalytic activity even under conditions where the 
holoenzyme populates the alkaline molten globule state. 
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Appendix 1 
 
Synthesis of 5-amino-6-methoxy-4,6-dioxohexanoic acid 
 
4-(Benzyloxy)-4-oxobutanoic acid (2). To an ice-cooled solution of benzyl alcohol (3.10 ml, 
30.0 mmol) in dichloromethane (Volume: 75 ml) was added triethylamine (6.25 ml, 44.8 mmol) 
and 4-dimethylaminopyridine (DMAP) (0.15 g, 1.228 mmol) followed by the dropwise addition 
of succinic anhydride (2.5 g, 24.98 mmol). The reaction mixture was stirred at room temperature 
overnight and washed with 1N HCl (2×30 mL) and brine (30 mL). The organic layer was dried 
on sodium sulfate and concentrated in vacuo. On standing, the oily product solidified.  The solid 
was shown to contain an impurity (likely from triethylamine), and thus, the solid was washed 
with water and hexane, and, lastly, dried under vacuum to give a white solid (2.76 g isolated).  
6-Benzyl 1-methyl 3-oxohexanedioate (3). A dry flask was charged with 4-(benzyloxy)-4-
oxobutanoic acid (1g, 4.80 mmol) and anhydrous THF (Volume: 10.67 ml) under an atmosphere 
of nitrogen.  To the solution was then added 1,1'-carbonyldiimidazole (CDI) (0.935 g, 5.76 
mmol) and the resulting mixture was stirred for 1 h at room temperature.  At this time, 
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magnesium chloride (0.457 g, 4.80 mmol) and potassium 3-methoxy-3-oxopropanoate (0.750 g, 
4.80 mmol) were both added at once.  The solution was then stirred overnight at 35 °C (oil bath).  
The resulting white slurry was filtered through celite, rinsed with THF, and the filtrate was 
concentrated in vacuo.  The residue was then diluted with ethyl acetate (EtOAc) and washed 
sequentially with 1M HCl, saturated NaHCO3, and brine.  The organic fraction was dried over 
Na2SO4.  1H-NMR and LC/MS showed mostly the expected product with a minor impurity. The 
material was used without further purification.  1H-NMR (CDCl3): 7.35 (5H, m), 5.12 (2H, s), 
3.73 (3H, s), 3.50 (2H, s), 2.88 (2H, t, J = 6.5 Hz), 2.68 (2H, t, J = 6.5 Hz).  LC/MS: 287 
(M+23).  
6-Benzyl 1-methyl 2-(hydroxyimino)-3-oxohexanedioate (4). A flask was charged with 6-
benzyl 1-methyl 3-oxohexanedioate (958 mg, 3.63 mmol) in acetic acid (14 ml) and cooled in an 
ice water bath (the solution solidified initially, it was then allowed to warm to the point of 
stirring).  Once cooled, a solution of sodium nitrite (375 mg, 5.44 mmol) in water (7 ml) was 
added dropwise (slowly over ~10 min, keeping the temperature below 10 °C).  The solution was 
then allowed to slowly warm to room temperature in the ice water bath.  Upon completion (by 
LC/MS), the solution was diluted with EtOAc and washed twice with water and twice with 
saturated NaHCO3.  The organic portion was dried over Na2SO4 and concentrated in vacuo to 
give 6-benzyl 1-methyl 2-(hydroxyimino)-3-oxohexanedioate (986 mg, 3.36 mmol, 93% yield).  
1H-NMR showed full conversion with trace impurities.  The material was used without further 
purification.  1H NMR (500 MHz, CDCl3) δ 7.44 – 7.28 (m, 5H), 5.13 (s, 2H), 3.90 (s, 2H), 3.16 
(t, J = 6.7 Hz, 2H), 2.72 (t, J = 6.8 Hz, 2H).  LC/MS: 316.0 (M+23). 
6-benzyl 1-methyl 2-((tert-butoxycarbonyl)amino)-3-oxohexanedioate (5). A round bottom 
flask was charged with 6-benzyl 1-methyl 2-(hydroxyimino)-3-oxohexanedioate (0.5 g, 1.705 
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mmol) in acetic acid (20 ml) and cooled to 0 °C.  To this solution was then added BOC2O (3.72 
g, 17.05 mmol), followed by the portion-wise addition of zinc dust (1.115 g, 17.05 mmol).  The 
reaction mixture was then warmed to 50 °C in an oil bath. LC/MS after 1 h showed complete 
consumption of the starting material and the solution was cooled to room temperature.  Water 
was then added and the mixture was filtered through celite, washing with dichloromethane.  The 
organic portion was then washed with saturated NaHCO3 and dried over Na2SO4.  The residue 
was purified on a 50 g SiO2 column using a hexane/EtOAc gradient (15% to 30%).  The clean 
fractions were combined to give 149 mg (23%) of the expected product (additional product was 
present in mixed fractions).  1H NMR (500 MHz, CDCl3) δ 7.43 – 7.28 (m, 5H), 5.72 (d, J = 6.9 
Hz, 1H), 5.12 (s, 1H), 5.10 (s, 2H), 3.80 (s, 3H), 2.88 (t, J = 6.5 Hz, 1H), 2.74 – 2.64 (m, 3H), 
1.44 (s, 9H).  LCMS: 402.1 (M+23). 
5-Amino-6-methoxy-4,6-dioxohexanoic acid hydrochloride (6). A vial was charged with 6-
benzyl 1-methyl 2-((tert-butoxycarbonyl)amino)-3-oxohexanedioate (75 mg, 0.198 mmol) and 
CH2Cl2 (1.5 ml).  To this solution was then added TFA (0.5 ml) and the mixture was stirred until 
deprotection was complete by LCMS (~30 min).  The reaction was then concentrated in vacuo.  
1H NMR and LC/MS showed only minor impurities so the material was carried forth in the next 
step. A round bottom flask was charged with 5% Pd/C (30 mg, 0.014 mmol) under an 
atmosphere of nitrogen.  To this was then added methanol (3 ml) and 6-benzyl 1-methyl 2-
amino-3-oxohexanedioate (55.3 mg, 0.198 mmol).  A hydrogen-filled balloon was then affixed 
to the reaction vessel and the flask was evacuated then purged with hydrogen three times.  The 
mixture was then vigorously stirred at room temperature.  LC/MS after 1 h showed complete 
cleavage of the benzyl ester.  The mixture was filtered through celite, washing with additional 
methanol.  Concentration gave 73 mg of crude product.  To this residue was then added 4N 
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HCl/dioxane and diethylether.  Partial concentration in vacuo resulted in the formation of a white 
solid which was shown to be the clean hydrochloride salt.  Filtration and concentration in vacuo 
gave 18 mg (40%) of 6.  1H NMR (500 MHz, D2O) δ 3.95 (s, 3H), 3.39 – 3.25 (m, 1H), 3.11 – 
2.97 (m, 1H), 2.75 (m, 2H).  The methine peak is obscured by the D2O peak, but it appears at 
5.38 (s, 1H) in DMSO-D6 (though DMSO obscures the methylene peaks).  LC/MS: 190.0 (M+1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
134 
 
 
 
 
Appendix 2 
 
ELSEVIER LICENSE 
TERMS AND CONDITIONS 
Jan 15, 2015 
 
This is a License Agreement between Bosko M Stojanovski ("You") and Elsevier 
("Elsevier") provided by Copyright Clearance Center ("CCC"). The license consists of your 
order details, the terms and conditions provided by Elsevier, and the payment terms and 
conditions. 
All payments must be made in full to CCC. For payment instructions, please see 
information listed at the bottom of this form.
Supplier 
Elsevier Limited 
The Boulevard,Langford Lane 
Kidlington,Oxford,OX5 1GB,UK 
Registered Company 
Number 1982084 
Customer name Bosko M Stojanovski 
License number 3550341395900 
License date Jan 15, 2015 
Licensed content publisher Elsevier 
Licensed content 
publication 
Biochimica et Biophysica Acta (BBA) - Proteins and 
Proteomics 
Licensed content title 
Catalytically active alkaline molten globular enzyme: Effect of 
pH and temperature on the structural integrity of 5-
aminolevulinate synthase 
Licensed content author Bosko M. Stojanovski,Leonid Breydo,Gregory A. Hunter,Vladimir N. Uversky,Gloria C. Ferreira 
Licensed content date December 2014 
Licensed content volume 
number 1844 
Licensed content issue 
number 12 
Number of pages 10 
135 
 
Start Page 2145 
End Page 2154 
Type of Use reuse in a thesis/dissertation 
Portion full article 
Format both print and electronic 
Are you the author of this 
Elsevier article? Yes 
Will you be translating? No 
Title of your 
thesis/dissertation  
5-Aminolevulinate synthase: Characterization of the catalytic 
mechanism, reaction selectivity, and structural plasticity 
Expected completion date Mar 2015 
Estimated size (number of 
pages) 150 
Elsevier VAT number GB 494 6272 12 
Permissions price 0.00 USD 
VAT/Local Sales Tax 0.00 USD / 0.00 GBP 
Total 0.00 USD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
